Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
x
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the Quarterly Period Ended November 30, 2011
o
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Commission File Number: 1-33376
SARATOGA INVESTMENT CORP.
(Exact name of registrant as specified in its charter)
Maryland
20-8700615
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
535 Madison Avenue New York, New York
10022
(Address of principal executive office)
(Zip Code)
(212) 906-7800
(Registrant’s telephone number, including area code)
Not applicable
(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes o No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (check one):
Large Accelerated Filer o
Accelerated Filer o
Non-Accelerated Filer x
Smaller Reporting Company o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
The number of shares of the registrant’s common stock, $0.001 par value, outstanding as of January 12, 2012 was 3,876,661.
FORM 10-Q FOR THE QUARTER ENDED NOVEMBER 30, 2011
TABLE OF CONTENTS
Page
PART I
FINANCIAL INFORMATION
Item 1.
Financial Statements
Consolidated Statements of Assets and Liabilities as of November 30, 2011 (unaudited) and February 28, 2011
3
Consolidated Statements of Operations for the three and nine months ended November 30, 2011 and 2010 (unaudited)
4
Consolidated Schedules of Investments as of November 30, 2011 (unaudited) and February 28, 2011
5
Consolidated Statements of Changes in Net Assets for the nine months ended November 30, 2011 and 2010 (unaudited)
11
Consolidated Statements of Cash Flows for the nine months ended November 30, 2011 and 2010 (unaudited)
12
Notes to Consolidated Financial Statements as of November 30, 2011 (unaudited)
13
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
35
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
51
Item 4.
Controls and Procedures
52
PART II
OTHER INFORMATION
53
Legal Proceedings
Item 1A.
Risk Factors
Unregistered Sales of Equity Securities and Use of Proceeds
Defaults upon Senior Securities
Removed and Reserved
Item 5.
Other Information
Item 6.
Exhibits
Signatures
54
2
Saratoga Investment Corp.
Consolidated Statements of Assets and Liabilities
As of
November 30, 2011
February 28, 2011
(unaudited)
ASSETS
Investments at fair value
Non-control/non-affiliate investments (amortized cost of $70,208,225 and $73,779,271, respectively)
$
60,003,928
57,292,723
Control investments (amortized cost of $24,362,779 and $27,364,350, respectively)
25,375,268
22,732,038
Total investments at fair value (amortized cost of $94,571,004 and $101,143,621, respectively)
85,379,196
80,024,761
Cash and cash equivalents
7,941,870
10,735,755
Cash and cash equivalents, securitization accounts
833,546
4,369,987
Outstanding interest rate cap at fair value (cost of $131,000 and $131,000, respectively)
1,157
16,265
Interest receivable, (net of reserve of $552,352 and $14,796, respectively)
1,295,797
1,666,083
Deferred credit facility financing costs, net
1,128,392
1,638,768
Management fee receivable
227,462
231,753
Other assets
2,966,063
85,166
Total assets
99,773,483
98,768,538
LIABILITIES
Revolving credit facility
—
4,500,000
Payable for unsettled trades
4,900,000
Dividend payable
1,966,447
Management and incentive fees payable
2,490,901
2,203,806
Accounts payable and accrued expenses
685,990
785,486
Interest and credit facility fees payable
45,833
67,792
Due to manager
284,580
240,000
Total liabilities
5,473,751
12,697,084
NET ASSETS
Common stock, par value $.001, 100,000,000 common shares authorized, 3,876,661 and 3,277,077 common shares issued and outstanding, respectively
3,877
3,277
Capital in excess of par value
161,632,864
153,768,680
Distribution in excess of net investment income
(14,627,476
)
(8,918,890
Accumulated net realized loss from investments and derivatives
(43,387,880
(37,548,016
Net unrealized depreciation on investments and derivatives
(9,321,653
(21,233,597
Total Net Assets
94,299,732
86,071,454
Total liabilities and Net Assets
NET ASSET VALUE PER SHARE
24.32
26.26
See accompanying notes to consolidated financial statements.
Consolidated Statements of Operations
For three months ended November 30
For nine months ended November 30
2011
2010
INVESTMENT INCOME
Interest from investments
Non-control/Non-affiliate investments
1,877,650
3,639,216
5,212,182
7,006,161
Control investments
1,155,241
941,281
3,095,304
2,410,803
Total interest income
3,032,891
4,580,497
8,307,486
9,416,964
Interest from cash and cash equivalents
1,567
2,460
6,815
3,642
Management fee income
501,920
508,674
1,512,091
1,523,530
Other income
92,671
238,579
71,192
Total investment income
3,629,049
5,091,631
10,064,971
11,015,328
EXPENSES
Interest and credit facility financing expenses
307,221
618,810
987,042
2,188,078
Base management fees
393,888
424,044
1,203,820
1,258,875
Professional fees
356,144
381,096
1,282,009
3,138,221
Administrator expenses
250,000
730,000
568,562
Incentive management fees
1,178,750
1,173,144
842,097
Insurance
145,105
170,684
448,786
536,934
Directors fees and expenses
51,000
48,000
153,000
320,844
General & administrative
121,019
100,961
290,232
306,558
Other expense
2,150
5,340
Expenses before expense waiver and reimbursement
2,805,277
3,156,739
5,942,326
9,491,216
Expense reimbursement
(258,562
Waiver of deferred incentive management fees
(2,636,146
Total expenses net of expense waiver and reimbursement
6,596,508
NET INVESTMENT INCOME
823,772
1,934,892
4,122,645
4,418,820
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:
Net realized loss from investments
(5,831,905
(13,731,107
(5,839,864
(16,280,370
Net unrealized appreciation on investments
11,221,387
15,107,701
11,927,052
24,546,024
Net unrealized appreciation/(depreciation) on derivatives
166
(1,366
(15,108
(19,797
Net gain on investments
5,389,648
1,375,228
6,072,080
8,245,857
NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS
6,213,420
3,310,120
10,194,725
12,664,677
WEIGHTED AVERAGE - BASIC AND DILUTED EARNINGS PER COMMON SHARE
1.88
1.20
3.10
5.86
WEIGHTED AVERAGE COMMON STOCK OUTSTANDING - BASIC AND DILUTED
3,310,021
2,752,914
3,287,979
2,162,832
Consolidated Schedule of Investments
Company (a)
Industry
Investment Interest Rate/Maturity
Principal/ Number of Shares
Cost
Fair Value ( c )
% of Net Assets
Non-control/Non-affiliated investments - 63.6% (b)
Coast Plating, Inc. (d)
Aerospace
First Lien Term Loan 11.74%, 9/13/2014
2,550,000
2.7
%
First Lien Term Loan 13.24%, 9/13/2014
950,000
1.0
Total Aerospace
3,500,000
3.7
Legacy Cabinets Holdings (d), (h)
Building Products
Common Stock Voting A-1
2,535
220,900
0.0
Common Stock Voting B-1
1,600
139,424
Legacy Cabinets, Inc. (d)
First Lien Term Loan 7.25%, 5/3/2014
307,408
213,095
0.2
Total Building Products
667,732
Targus Group International, Inc. (d)
Consumer Products
First Lien Term Loan 11.00%, 5/24/2016
3,990,000
3,917,632
3,928,155
4.2
Targus Holdings, Inc. (d)
Unsecured Notes 10.00%, 6/14/2019
1,692,059
888,500
0.9
Targus Holdings, Inc. (d), (h)
Common Stock
62,413
566,765
2,932,787
3.1
Total Consumer Products
6,176,456
7,749,442
8.2
CFF Acquisition LLC (d)
Consumer Services
First Lien Term Loan 7.50%, 7/31/2015
2,817,889
2,580,428
2,489,887
2.6
PrePaid Legal Services, Inc. (d)
First Lien Term Loan 11.00%, 12/31/2016
3,000,000
2,916,310
3.2
Total Consumer Services
5,496,738
5,489,887
5.8
M/C Acquisition Corp., LLC (d)
Education
First Lien Term Loan 6.75%, 12/31/2012
2,938,192
1,787,165
716,625
0.8
M/C Acquisition Corp., LLC (d), (h)
Class A Common Stock
544,761
30,242
Total Education
1,817,407
Advanced Lighting Technologies, Inc. (d)
Electronics
Second Lien Term Loan 6.26%, 6/1/2014
2,000,000
1,891,210
1,870,000
2.0
Group Dekko, Inc. (fka Dekko Technologies, LLC) (d)
Second Lien Term Loan 10.50%, 5/1/2013
7,494,283
6,894,740
7.3
Total Electronics
9,385,493
8,764,740
9.3
USS Parent Holding Corp. (d), (h)
Environmental
Non Voting Common Stock
765
133,002
99,080
0.1
Voting Common Stock
17,396
3,025,798
2,254,058
2.4
Total Environmental
3,158,800
2,353,138
2.5
Bankruptcy Management Solutions, Inc. (d)
Financial Services
Second Lien Term Loan 8.37%, 8/20/2015
2,479,858
51,829
Bankruptcy Management Solutions, Inc. (d), (h)
27,197
Warrants
2,510
DCS Business Services, Inc. (d)
First Lien Term Loan 13.75%, 9/30/2012
1,600,000
1,606,371
1.7
Total Financial Services
4,086,229
1,651,829
1.8
Big Train, Inc. (d)
Food and Beverage
First Lien Term Loan 7.75%, 3/31/2012
1,479,060
1,410,059
1,436,019
1.4
PRACS Institute, LTD (d), (h)
Healthcare Services
Second Lien Term Loan 10.00%, 4/17/2013
4,093,750
4,078,296
Maverick Healthcare Group (d)
First Lien Term Loan 10.75%, 12/31/2016
4,962,500
4,875,767
4,813,625
5.1
Total Healthcare Services
8,954,063
McMillin Companies LLC (d)
Homebuilding
Senior Secured Notes 9.53%, 12/31/2013
990,000
970,393
735,374
Worldwide Express Operations, LLC (d)
Logistics
First Lien Term Loan 10.00%, 6/30/2013
6,698,151
6,380,051
6,185,072
6.6
Capstone Logistics, LLC (d)
First Lien Term Loan 7.50%, 9/16/2016
1,000,000
985,017
1.1
First Lien Term Loan 13.50%, 9/16/2016
4,000,000
3,940,069
Total Logistics
11,305,137
11,185,072
11.9
Elyria Foundry Company, LLC (d)
Metals
Senior Secured Notes 17.00%, 3/1/2013
7,428,456
7,170,143
6,670,753
7.1
Elyria Foundry Company, LLC (d), (h)
Warrants to Purchase Limited Liability Company Interests
3,000
Total Metals
Network Communications, Inc. (d)
Publishing
Unsecured Notes 8.60%, 1/14/2020
2,378,181
1,880,328
1,067,090
Network Communications, Inc. (d), (h)
211,429
710,401
Penton Media, Inc. (d)
First Lien Term Loan 5.00%, 8/1/2014
4,839,609
4,229,248
2,946,838
Total Publishing
6,109,576
4,724,329
5.0
Sub Total Non-control/Non-affiliated investments
70,208,225
63.6
Control investments - 26.9% (b)
GSC Partners CDO GP III, LP (g), (h)
100% General Partnership Interest
GSC Investment Corp. CLO 2007 LTD. (d), (e), (g)
Structured Finance Securities
Other/Structured Finance Securities 19.20%, 1/21/2020
30,000,000
24,362,779
26.9
Sub Total Control investments
Affiliate investments - 0.0% (b)
GSC Partners CDO GP III, LP (f), (h)
6.24% Limited Partnership Interest
Sub Total Affiliate investments
TOTAL INVESTMENTS - 90.5% (b)
94,571,004
90.5
Outstanding interest rate cap
Interest rate
Maturity
Notional
Fair Value
Interest rate cap
8.0
2/9/2014
22,040,816
87,000
843
11/30/2013
10,332,000
44,000
314
Total Outstanding interest rate cap
131,000
%*
6
* Amounts to less than 0.05%
(a) All of our equity and debt investments are issued by eligible portfolio companies, as defined in the Investment Company Act of 1940, except GSC Investment Corp. CLO 2007 Ltd. and GSC Partners CDO GP III, LP.
(b) Percentages are based on net assets of $94,299,732 as of November 30, 2011.
(c) Because there is no readily available market value for these investments, the fair value of all of our investments is determined in good faith by our board of directors. (see Note 3 to the consolidated financial statements).
(d) These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).
(e) 19.20% represents the modeled effective interest rate that is expected to be earned over the life of the investment.
(f) As defined in the Investment Company Act, we are an “Affiliate” of this portfolio company because we own 5% or more of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was an Affiliate are as follows:
Interest
Management
Net Realized
Net Unrealized
Company
Purchases
Redemptions
Sales (cost)
Income
fee income
gains/(losses)
GSC Partners CDO GP III, LP
(g) As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:
GSC Investment Corp. CLO 2007 LTD.
5,644,800
(h) Non-income producing at November 30, 2011.
7
Non-control/Non-affiliated investments — 66.6% (b)
Legacy Cabinets Holdings (d), (i)
Legacy Cabinets, Inc. (d), (i)
293,474
154,455
653,798
Hopkins Manufacturing Corporation (d)
Second Lien Term Loan 7.54%, 1/26/2012
3,250,000
3,249,024
3,233,750
First Lien Term Loan 8.75%, 11/22/2012
3,169,227
3,057,616
3,147,834
Unsecured Notes 10.00%, 12/14/2015
1,538,235
985,547
Targus Holdings, Inc. (d), (i)
2,881,608
3.3
8,411,640
10,248,739
11.8
285,876
244,424
0.3
First Lien Term Loan 1.00%, 12/31/2012
870,791
258,625
M/C Acquisition Corp., LLC (d), (i)
166,327
30,241
901,032
Second Lien Term Loan 6.29%, 6/1/2014
1,858,442
1,867,092
2.2
Dekko Technologies, LLC (d)
Second Lien Term Loan 10.50%, 1/20/2012
7,198,935
6,766,999
7.9
9,057,377
8,634,091
10.1
USS Parent Holding Corp. (d), (i)
124,311
2,828,080
2,952,391
3.4
Second Lien Term Loan 1.25%, 8/20/2015
2,450,499
110,272
Bankruptcy Management Solutions, Inc. (d), (i)
DCS Business Services, Inc.
1,612,135
4,062,634
1,710,272
1,687,008
1,403,224
1,545,637
PRACS Institute, LTD (d)
4,069,847
3,014,420
3.5
5,000,000
8,969,847
8,014,420
Senior Secured Notes 9.53%, 10/31/2013
1,100,000
1,067,024
816,200
2,865,629
2,862,910
2,498,828
2.9
8
Jason Incorporated (d), (i)
Manufacturing
Senior Secured Notes 10.25%, 12/21/2015
2,414,272
2,391,318
2.8
Specialized Technology Resources, Inc. (d)
Second Lien Term Loan 7.26%, 12/15/2014
4,833,437
4,966,500
Total Manufacturing
7,247,709
7,357,818
8.6
5,100,000
5,017,225
4,231,222
4.9
Elyria Foundry Company, LLC (d), (i)
Grant U.S. Holdings LLP (d), (e), (i)
Natural Resources
Second Lien Term Loan 0.00%, 9/20/2013
6,349,512
6,349,348
Energy Alloys, LLC (d), (i)
Oil and Gas
Second Lien Term Loan 3.00%, 6/30/2015
6,429,092
316,954
0.4
Total Oil and Gas
Terphane Holdings Corp. (d), (e), (i)
Packaging
Senior Secured Notes 14.00%, 6/15/2015
2,500,000
2,453,252
Network Communications, Inc. (d), (i)
1,285,714
929,314
900,688
4,839,376
4,116,021
4,025,393
4.7
5,401,735
5,855,395
6.8
73,779,271
66.6
Control investments — 26.4% (b)
GSC Partners CDO GP III, LP (h), (i)
GSC Investment Corp. CLO 2007 LTD. (d), (f), (h)
Other/Structured Finance Securities 11.99%, 1/21/2020
27,364,350
26.4
Affiliate investments — 0.0% (b)
GSC Partners CDO GP III, LP (g), (i)
TOTAL INVESTMENTS — 93.0% (b)
101,143,621
93.0
29,387,755
11,893
23,966,000
4,372
(a) All of our equity and debt investments are issued by eligible portfolio companies, as defined in the Investment Company Act of 1940, except Grant U.S. Holdings LLP, GSC Investment Corp. CLO 2007 Ltd., Terphane Holdings Corp., and GSC Partners CDO GP III, LP.
(b) Percentages are based on net assets of $86,071,454 as of February 28, 2011.
(e) Non-U.S. company. The principal place of business for Terphane Holdings Corp. is Brazil, and for Grant U.S. Holdings LLP is Canada.
(f) 11.99% represents the modeled effective interest rate that is expected to be earned over the life of the investment.
(g) As defined in the Investment Company Act, we are an “Affiliate” of this portfolio company because we own 5% or more of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was an Affiliate are as follows:
9
(i) As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we control are as follows:
3,295,359
2,032,357
7,902,482
(i) Non-income producing at February 28, 2011.
10
Consolidated Statements of Changes in Net Assets
For nine months ended November 30, 2011
For nine months ended November 30, 2010
INCREASE FROM OPERATIONS:
Net investment income
Net unrealized depreciation on derivatives
Net increase in net assets from operations
DECREASE FROM SHAREHOLDER DISTRIBUTIONS:
Distributions declared
(9,831,231
(1,179,800
Net decrease in net assets from shareholder distributions
CAPITAL SHARE TRANSACTIONS:
Stock dividend distribution
7,864,784
Issuance of common stock, net of issuance costs
14,814,860
Net increase in net assets from capital share transactions
Total increase in net assets
8,228,278
26,299,737
Net assets at beginning of period
55,478,152
Net assets at end of period
81,777,889
Net asset value per common share
24.95
Common shares outstanding at end of period
3,876,661
3,277,077
(10,223,021
Consolidated Statements of Cash Flows
Operating activities
NET INCREASE IN NET ASSETS FROM OPERATIONS
ADJUSTMENTS TO RECONCILE NET INCREASE IN NET ASSETS FROM OPERATIONS TO NET CASH PROVIDED BY OPERATING ACTIVITIES:
Paid-in-kind interest income
(1,188,674
(869,054
Net accretion of discount on investments
(1,002,986
(548,994
Amortization of deferred credit facility financing costs
510,376
230,133
Reversal of deferred incentive management fees
Net realized (gain) loss from investments
5,839,864
16,280,370
Net unrealized (appreciation) depreciation on investments
(11,927,052
(24,546,024
Net unrealized (appreciation) depreciation on derivatives
15,108
19,797
Proceeds from sale and redemption of investments
31,873,349
9,455,897
Purchase of investments
(28,948,936
(Increase) decrease in operating assets:
3,536,441
(3,181,836
Interest receivable
370,286
1,456,154
4,291
96,090
(2,880,897
(125,973
Increase (decrease) in operating liabilities:
(4,900,000
287,095
1,433,797
(99,496
(225,784
(21,959
(114,718
44,580
294,398
NET CASH PROVIDED BY OPERATING ACTIVITIES
1,706,115
9,682,784
Financing activities
Issuance of shares of common stock
15,000,002
Payment of common stock issuance costs
(185,140
Borrowings on debt
20,000,000
Paydowns on debt
(4,500,000
(41,242,222
Credit facility financing cost
(2,035,932
NET CASH USED BY FINANCING ACTIVITIES
(8,463,292
NET INCREASE/(DECREASE) IN CASH AND CASH EQUIVALENTS
(2,793,885
1,219,492
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD
3,352,434
CASH AND CASH EQUIVALENTS, END OF PERIOD
4,571,926
Supplemental information:
Interest paid during the period
498,625
2,072,663
Supplemental non-cash information
1,188,674
869,054
1,002,986
548,994
2,636,146
10,615,905
Cash dividend payable
1,179,800
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 1. Organization and Basis of Presentation
Saratoga Investment Corp. (the “Company”, “we”, “our” and “us”) is a non-diversified closed end management investment company incorporated in Maryland that has elected to be treated and is regulated as a business development company (“BDC”) under the Investment Company Act of 1940 (the “1940 Act”). We commenced operations on March 23, 2007 as GSC Investment Corp. and completed our initial public offering (“IPO”) on March 28, 2007. We have elected to be treated as a regulated investment company (“RIC”) under subchapter M of the Internal Revenue Code (the “Code”). We expect to continue to qualify and to elect to be treated for tax purposes as a RIC. Our investment objective is to generate current income and, to a lesser extent, capital appreciation from our investments.
GSC Investment, LLC (the “LLC”) was organized in May 2006 as a Maryland limited liability company. As of February 28, 2007, the LLC had not yet commenced its operations and investment activities.
On March 21, 2007, the Company was incorporated and concurrently therewith the LLC was merged with and into the Company, with the Company as the surviving entity, in accordance with the procedure for such merger in the LLC’s limited liability company agreement and Maryland law. In connection with such merger, each outstanding limited liability company interest of the LLC was converted into a share of common stock of the Company.
On July 30, 2010, the Company changed its name from “GSC Investment Corp.” to “Saratoga Investment Corp.” in conjunction with the transaction described in “Note 13. Recapitalization Transaction” below.
We are externally managed and advised by our investment adviser, Saratoga Investment Advisors, LLC (the “Manager”), pursuant to an investment advisory and management agreement. Prior to July 30, 2010, we were managed and advised by GSCP (NJ), L.P.
The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“GAAP”) and include the accounts of the Company and its special purpose financing subsidiary, Saratoga Investment Funding, LLC (previously known as GSC Investment Funding LLC). All intercompany accounts and transactions have been eliminated in consolidation. All references made to the “Company,” “we,” and “us” herein include Saratoga Investment Corp. and its consolidated subsidiary, except as stated otherwise.
Note 2. Summary of Significant Accounting Policies
Use of Estimates in the Preparation of Financial Statements
The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements, and income, gains/(losses) and expenses during the period reported. Actual results could differ materially from those estimates.
Cash and Cash Equivalents
Cash and cash equivalents include short-term, liquid investments in a money market fund. Cash and cash equivalents are carried at cost which approximates fair value. Per section 12(d)(1)(A) of the 1940 Act, the Company may not invest in another registered investment company such as, a money market fund if such investment would cause the Company to exceed any of the following limitations:
· we were to own more than 3% of the total outstanding voting stock of the money market fund;
· we were to hold securities in the money market fund having an aggregate value in excess of 5% of the value of our total assets or
· we were to hold securities in money market funds and other registered investment companies and BDCs having an aggregate value in excess of 10% of the value of our total assets.
Cash and Cash Equivalents, Securitization Accounts
Cash and cash equivalents, securitization accounts include amounts held in designated bank accounts in the form of cash and short-term liquid investments in money market funds representing payments received on securitized investments or other reserved amounts associated with our $40 million senior secured revolving credit facility with Madison Capital Funding LLC. The Company is required to use a portion of these amounts to pay interest expense, reduce borrowings, or pay other amounts in accordance with the terms of the senior secured revolving credit facility. Cash held in such accounts may not be available for the general use of the Company.
Investment Classification
The Company classifies its investments in accordance with the requirements of the 1940 Act. Under the 1940 Act, “Control Investments” are defined as investments in companies in which we own more than 25% of the voting securities or maintain greater than 50% of the board representation. Under the 1940 Act, “Affiliated Investments” are defined as those non-control investments in companies in which we own between 5% and 25% of the voting securities. Under the 1940 Act, “Non-affiliated Investments” are defined as investments that are neither Control Investments nor Affiliated Investments.
Investment Valuation
The Company accounts for its investments at fair value in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold at the statement of assets and liabilities date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.
Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third party pricing services and market makers subject to any decision by our board of directors to make a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as determined, in good faith, by our board of directors based on input from our Manager, the audit committee of our board of directors and a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors.
We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:
· Each investment is initially valued by the responsible investment professionals of our Manager and preliminary valuation conclusions are documented and discussed with our senior management; and
· An independent valuation firm engaged by our board of directors reviews approximately one quarter of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least annually.
In addition, all our investments are subject to the following valuation process.
· The audit committee of our board of directors reviews each preliminary valuation and our Manager and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and
· Our board of directors discusses the valuations and determines the fair value of each investment, in good faith, based on the input of our Manager, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.
14
Our investment in GSC Investment Corp. CLO 2007, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.
Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value by our board of directors may differ materially from the values that would have been used if a ready market for these investments existed. Our net asset value could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that we ultimately realize upon the disposal of such investments.
Derivative Financial Instruments
We account for derivative financial instruments in accordance with ASC Topic 815, Derivatives and Hedging (“ASC 815”). ASC 815 requires recognizing all derivative instruments as either assets or liabilities on the consolidated statements of assets and liabilities at fair value. The Company values derivative contracts at the closing fair value provided by the counterparty. Changes in the values of derivative contracts are included in the consolidated statements of operations.
Investment Transactions and Income Recognition
Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortizations of premium on investments.
Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.
Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.
Paid-in-Kind Interest
The Company holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.
15
Deferred Credit Facility Financing Costs
Financing costs incurred in connection with our credit facilities are deferred and amortized using the straight line method over the life of the respective facility.
Indemnifications
In the ordinary course of its business, the Company may enter into contracts or agreements that contain indemnifications or warranties. Future events could occur that lead to the execution of these provisions against the Company. Based on its history and experience, management feels that the likelihood of such an event is remote.
Income Taxes
The Company has filed an election to be treated for tax purposes as a RIC under Subchapter M of the Code and, among other things, intends to make the requisite distributions to its stockholders which will relieve the Company from federal income taxes. Therefore, no provision has been recorded for the obligation to pay federal income taxes.
In order to qualify as a RIC, among other requirements, the Company is required to timely distribute to its stockholders at least 90% of its investment company taxable income, as defined by the Code, for each fiscal tax year. The Company will be subject to a nondeductible U.S. federal excise tax of 4% on undistributed income if it does not distribute at least 98% of its ordinary income in any calendar year and 98.2% of its capital gain net income for each one-year period ending on October 31.
Depending on the level of taxable income earned in a tax year, the Company may choose to carry forward taxable income in excess of current year dividend distributions into the next tax year and pay a 4% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year dividend distributions for excise tax purposes, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned.
In accordance with certain applicable Treasury regulations and private letter rulings issued by the Internal Revenue Service, a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20% of the aggregate declared distribution. If too many stockholders elect to receive cash, each stockholder electing to receive cash will receive a pro rata amount of cash (with the balance of the distribution paid in stock). In no event will any stockholder, electing to receive cash, receive less than 20% of his or her entire distribution in cash. If these and certain other requirements are met, for U.S federal income tax purposes, the amount of the dividend paid in stock will be equal to the amount of cash that could have been received instead of stock.
ASC 740, Income Taxes provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax positions deemed to meet a “more-likely-than-not” threshold would be recorded as a tax benefit or expense in the current period. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense in the consolidated statement of operations. As of November 30, 2011 and February 28, 2011, there were no uncertain tax positions.
Dividends
Dividends to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the board of directors. Net realized capital gains, if any, are generally distributed at least annually, although we may decide to retain such capital gains for reinvestment.
We have adopted a dividend reinvestment plan that provides for reinvestment of our dividend distributions on behalf of our stockholders unless a stockholder elects to receive cash. As a result, if our board of directors authorizes, and we declare, a cash dividend, then our stockholders who have not “opted out” of our dividend reinvestment plan will have their cash dividends automatically reinvested in additional shares of our common stock, rather than receiving the cash dividends. If our common stock is trading below net asset value at the time of valuation, the plan administrator may receive the dividend or distribution in cash and purchase common stock in the open market, on the New York Stock Exchange or elsewhere, for the account of each participant in our dividend reinvestment plan.
Capital Gains Incentive Fee
The Company records an expense accrual relating to the capital gains incentive fee payable by the Company to its investment adviser when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the investment adviser if the Company were to liquidate its investment portfolio at such time. The actual incentive fee payable to the Company’s investment adviser related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains for the period.
16
New Accounting Pronouncements
In May 2011, the FASB issued (“ASU”) No. 2011-04, Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs (“ASU 2011-04”), which amends U.S. GAAP to conform it with fair value measurement and disclosure requirements in International Financial Reporting Standards (“IFRS”). The amendments in ASU 2011-04 change the wording used to describe the requirements in U.S. GAAP for measuring fair value and for disclosing information about fair value measurements. We are currently evaluating the impact this accounting standards update will have on our consolidated financial statements. The amendments in ASU 2011-04 are to be applied prospectively and are effective during interim and annual periods beginning after December 15, 2011.
Risk Management
In the ordinary course of its business, the Company manages a variety of risks, including market risk and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.
Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount.
The Company is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in securitization accounts, at a major financial institution and credit risk related to any of its derivative counterparties.
The Company has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities, because such investments are generally unsecured and are often subordinated to other creditors of the issuer.
Note 3. Investments
As noted above, the Company values all investments in accordance with ASC 820. ASC 820 requires enhanced disclosures about assets and liabilities that are measured and reported at fair value. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.
ASC 820 establishes a hierarchal disclosure framework which prioritizes and ranks the level of market price observability of inputs used in measuring investments at fair value. Market price observability is affected by a number of factors, including the type of investment and the characteristics specific to the investment. Investments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.
Based on the observability of the inputs used in the valuation techniques, the Company is required to provide disclosures on fair value measurements according to the fair value hierarchy. The fair value hierarchy ranks the observability of the inputs used to determine fair values. Investments carried at fair value are classified and disclosed in one of the following three categories:
· Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.
· Level 2—Valuations based on inputs other than quoted prices in active markets, which are either directly or indirectly observable.
· Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The inputs used in the determination of fair value may require significant management judgment or estimation. Such information may be the result of consensus pricing information or broker quotes which include a disclaimer that the broker would not be held to such a price in an actual transaction. The non-binding nature of consensus pricing and/or quotes accompanied by disclaimer would result in classification as a Level 3 asset, assuming no additional corroborating evidence.
In addition to using the above inputs in investment valuations, the Company continues to employ the valuation policy approved by the board of directors that is consistent with ASC 820 (see Note 2). Consistent with our Company’s valuation policy, we evaluate the source of inputs, including any markets in which our investments are trading, in determining fair value.
17
The following table presents fair value measurements of investments, by major class, as of November 30, 2011 (dollars in thousands), according to the fair value hierarchy:
Fair Value Measurements
Level 1
Level 2
Level 3
Total
First lien term loans
35,830
Second lien term loans
8,816
Senior secured notes
7,405
Unsecured notes
1,956
Structured finance securities
25,375
Common stock/equities
5,997
Limited partnership interest
85,379
The following table presents fair value measurements of investments, by major class, as of February 28, 2011 (dollars in thousands), according to the fair value hierarchy:
18,475
20,276
9,892
1,915
22,732
6,735
80,025
The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the nine months ended November 30, 2011 (dollars in thousands):
Balance as of February 28, 2011
Net unrealized gains (losses)
(1,680
9,036
372
(708
5,645
(738
11,927
Purchases and other adjustments to cost
27,528
512
2,352
749
31,141
Sales and redemptions
(8,507
(14,808
(5,215
(3,002
(342
(31,874
Net realized gain (loss) from investments
(6,200
342
(5,840
Balance as of November 30, 2011
Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.
Sales and redemptions represent net proceeds received from investments sold, and principal paydowns received, during the period.
The net change in unrealized gain/(loss) on investments held as of November 30, 2011 is $(396,130) and is included in net unrealized appreciation (depreciation) on investments in the Consolidated Statements of Operations.
18
The composition of our investments as of November 30, 2011, at amortized cost and fair value were as follows (dollars in thousands):
Investments at Amortized Cost
Amortized Cost Percentage of Total Portfolio
Investments at Fair Value
Fair Value Percentage of Total Portfolio
38,435
40.5
42.0
15,944
16.9
10.3
8,141
8.7
3,572
3.8
2.3
24,363
25.8
29.7
4,116
4.4
7.0
94,571
100
The composition of our investments as of February 28, 2011, at amortized cost and fair value were as follows (dollars in thousands):
19,402
19.2
23.1
36,439
36.0
25.3
10,999
10.9
12.4
2,824
27,364
27.0
28.4
4.1
8.4
101,144
100.0
For loans and debt securities for which market quotations are not available, we determine their fair value based on third party indicative broker quotes, where available, or the assumptions that a hypothetical market participant would use to value the security in a current hypothetical sale using a market yield valuation methodology. In applying the market yield valuation methodology, we determine the fair value based on such factors as market participant assumptions including synthetic credit ratings, estimated remaining life, current market yield and interest rate spreads of similar securities as of the measurement date. If, in our judgment, the market yield methodology is not sufficient or appropriate, we may use additional methodologies such as an asset liquidation or expected recovery model.
For equity securities of portfolio companies and partnership interests, we determine the fair value of the portfolio company based on the market approach with value then attributed to equity or equity like securities using the enterprise value waterfall valuation methodology. Under the enterprise value waterfall valuation methodology, we determine the enterprise fair value of the portfolio company and then waterfall the enterprise value over the portfolio company’s securities in order of their preference relative to one another. To estimate the enterprise value of the portfolio company, we weigh some or all of the traditional market valuation methods and factors based on the individual circumstances of the portfolio company in order to estimate the enterprise value. The methodologies for performing investments may be based on, among other things: valuations of comparable public companies, recent sales of private and public comparable companies, discounting the forecasted cash flows of the portfolio company, third party valuations of the portfolio company, considering offers from third parties to buy the company, estimating the value to potential strategic buyers and considering the value of recent investments in the equity securities of the portfolio company. For non-performing investments, we may estimate the liquidation or collateral value of the portfolio company’s assets and liabilities. We also take into account historical and anticipated financial results.
19
Our investment in Saratoga CLO is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We used the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO at November 30, 2011. The significant inputs for the valuation model included:
· Default rates: 3.0%
· Recovery rates: 70%
· Reinvestment rates: LIBOR plus 400 basis points
· Prepayment rate: 20%
Note 4. Investment in GSC Investment Corp. CLO 2007, Ltd. (“Saratoga CLO”)
On January 22, 2008, we invested $30 million in all of the outstanding subordinated notes of Saratoga CLO (which are referred in the unaudited balance sheet of Saratoga CLO below as “Preference shares”), a collateralized loan obligation fund managed by us that invests primarily in senior secured loans. Additionally, we entered into a collateral management agreement with Saratoga CLO pursuant to which we act as collateral manager to it. In return for our collateral management services, we are entitled to a senior collateral management fee of 0.10% and a subordinate collateral management fee of 0.40% of the outstanding principal amount of Saratoga CLO’s assets, to be paid quarterly to the extent of available proceeds. We are also entitled to an incentive management fee equal to 20% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return equal to or greater than 12%. For the three months ended November 30, 2011 and November 30, 2010, we accrued $0.5 million and $0.5 million in collateral management fee income, respectively, due from Saratoga CLO and $1.2 million and $0.9 million in interest income, respectively, due from Saratoga CLO. For the nine months ended November 30, 2011 and November 30, 2010, we accrued $1.5 million and $1.5 million in collateral management fee income, respectively, due from Saratoga CLO and $3.1 million and $2.4 million in interest income, respectively, due from Saratoga CLO. We did not accrue any amounts related to the incentive management fee as the 12% hurdle rate has not yet been achieved.
At November 30, 2011, the Company determined that the fair value of its investment in the subordinated notes of Saratoga CLO was $25.4 million, whereas the net asset value of Saratoga CLO on such date was $16.7 million. The Company does not believe that the net asset value of Saratoga CLO, which is the difference between Saratoga CLO’s assets and liabilities at a given point in time, necessarily equates to the fair value of its investment in the subordinated notes of Saratoga CLO. Specifically, the Company determines the fair value of its investment in the subordinated notes of Saratoga CLO based on the present value of the projected future cash flows of the subordinated notes over the life of Saratoga CLO. At November 30, 2011, Saratoga CLO had investments with a principal balance of $389.5 million and a weighted average spread over LIBOR of 3.5%, and had debt of $364.0 million with a weighted average spread over LIBOR of 1.4%. As a result, Saratoga CLO earns a “spread” between the interest income it receives on its investments and the interest expense it pays on its debt and other operating expenses, which is distributed quarterly to the Company as the holder of its subordinated notes. At November 30, 2011, the total “spread”, or projected future cash flows of the subordinated notes, over the life of Saratoga CLO was $48.3 million, which had a present value of approximately $25.9 million, using a 20% discount rate. At November 30, 2011, the fair value of the subordinated notes, which we based upon the present value of the projected cash flows, was $25.4 million, which was greater than the net asset value of Saratoga CLO on such date by approximately $8.7 million.
Below is certain summary financial information from the separate unaudited financial statements of Saratoga CLO as of November 30, 2011 and February 28, 2011 and for the nine months ended November 30, 2011 and November 30, 2010.
20
Note 4. Investment in GSC Investment Corp. CLO 2007, Ltd.
GSC Investment Corp. CLO 2007
Balance Sheet
Investments
Fair Value Loans
368,096,647
373,564,517
Fair Value Bonds
2,243,464
Fair Value Other/Structured finance securities
15,583,573
15,362,136
Total investments at fair value
383,680,220
391,170,117
7,061,884
19,887,581
Receivable from open trades
3,222,500
1,625,828
1,737,017
Deferred bond issuance
3,000,700
3,545,449
398,591,132
416,340,164
Interest payable
781,996
701,640
Payable from open trades
17,317,146
25,151,104
Accrued senior collateral monitoring fee
45,491
46,351
Accrued subordinate collateral monitoring fee
181,969
185,402
Class A notes
296,000,000
Class B notes
22,000,000
Discount on class B notes
(492,560
(538,121
Class C notes
14,000,000
Class D notes
16,000,000
Discount on class D notes
(521,055
(569,252
Class E notes
17,960,044
Discount on class E notes
(1,340,364
(1,464,346
381,932,667
389,472,822
PARTNERS’ CAPITAL
Preference shares principal
Preferred shares
9,478,573
(14,270,311
Partners distributions
(18,548,938
(12,611,230
Net income / (loss)
(4,271,170
23,748,883
Total capital
16,658,465
26,867,342
Total liabilities and partners’ capital
21
Statement of Operations
For the three months ended November 30
For the nine months ended November 30
4,938,100
5,340,612
15,158,477
16,122,093
1,283
6,336
6,976
14,406
89,338
117,536
439,255
222,011
5,028,721
5,464,484
15,604,708
16,358,510
Interest expense
1,615,662
1,698,872
4,793,580
4,995,119
50,075
27,089
307,156
204,056
Misc. Fee Expense
11,757
158,416
438
Senior collateral monitoring fee
100,384
101,735
302,418
304,706
Subordinate collateral monitoring fee
401,536
406,939
1,209,673
1,218,824
Trustee expenses
25,291
25,643
75,374
75,975
Amortization expense
253,635
762,489
Total expenses
2,458,340
2,513,913
7,609,106
7,561,607
2,570,381
2,950,571
7,995,602
8,796,903
Net realized gain/(loss) on investments
106,318
1,915,085
(5,075,060
2,358,744
Net unrealized appreciation/(depreciation) on investments
6,446,956
(2,947,496
(7,191,712
4,400,318
Net gain/(loss) on investments
6,553,274
(1,032,411
(12,266,772
6,759,062
NET INCREASE/(DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS
9,123,655
1,918,160
15,555,965
22
GSC Investment Corp.
Issuer_Name
Asset_Name
Asset_Type
Current Rate
Maturity Date
Principal / Number of Shares
Elyria Foundry Company, LLC
Equity
0.00
2,000
Network Communications, Inc.
Common
169,143
659,658
OLD AII, Inc (fka Aleris International Inc.)
2,624
224,656
128,576
PATS Aircraft, LLC
51,813
282,326
282,329
SuperMedia Inc. (fka Idearc Inc.)
10,821
28,784
5,411
Academy, LTD.
Initial Term Loan
First Lien Term Loans
6.00
8/3/2018
1,985,591
1,955,620
Acosta, Inc.
Term B Loan
4.75
3/1/2018
4,254,136
4,185,434
4,115,877
Advanced Lighting Technologies, Inc.
Deferred Draw Term Loan (First Lien)
3.02
6/1/2013
251,962
240,232
237,474
Term Loan (First Lien)
3.01
4,615,472
4,489,270
4,350,083
Aeroflex Incorporated
Tranche B Term Loan
4.25
5/9/2018
3,971,600
3,760,575
Aerostructures Acquisition LLC
Term Loan
7.25
3/1/2013
563,527
549,852
540,986
Aptalis Pharma, Inc. (fka Axcan Intermediate Holdings Inc.)
5.50
2/10/2017
1,985,000
1,976,383
1,885,750
Ashland Inc.
3.75
8/23/2018
997,590
1,000,520
Asurion, LLC (fka Asurion Corporation)
5/24/2018
5,727,273
5,673,860
5,510,725
Aurora Diagnostics, LLC
6.25
5/26/2016
508,611
494,309
Autotrader.com, Inc.
Tranche B-1 Term Loan
4.00
12/15/2016
3,879,505
3,863,327
Avantor Performance Materials Holdings, Inc.
5.00
6/24/2017
4,987,500
4,964,159
4,788,000
AZ Chem US Inc.
New Term Loan
11/21/2016
559,574
552,249
558,332
2,299,617
2,303,846
2,294,512
BakerCorp International, Inc. (f/k/a B-Corp Holdings, Inc.)
6/1/2018
498,750
496,434
493,014
Bass Pro Group, LLC
5.25
6/13/2017
2,992,500
2,964,884
2,913,318
BJ’s Wholesale Club, Inc.
Initial Loan (First Lien)
7.00
9/28/2018
1,902,274
1,993,920
C.H.I. Overhead Doors, Inc. (CHI)
8/17/2017
3,087,250
3,027,868
3,010,069
Capstone Logistics, LLC
Term A Note
7.50
9/16/2016
2,955,051
2,955,000
Capsugel Holdings US, Inc.
8/1/2018
3,989,184
3,994,360
Celanese US Holdings LLC
Dollar Term C Loan (Extended)
3.12
10/31/2016
3,473,618
3,517,406
3,471,221
Cenveo Corporation
Term B Facility
12/21/2016
2,977,500
2,952,400
2,925,394
Charter Communications Operating, LLC
Term C Loan
3.62
9/6/2016
3,989,848
3,982,768
3,908,375
CHS/ Community Health Systems, Inc.
Extended Term Loan
3.95
1/25/2017
1,350,219
1,334,075
1,301,692
Non-Extended Delayed Draw Term Loan
2.51
7/25/2014
138,284
135,604
133,197
Non-Extended Term Loan
2.75
2,690,504
2,639,971
2,591,520
Cinedigm Digital Funding I, LLC
4/29/2016
1,576,813
1,565,156
1,513,741
Cinemark USA, Inc.
3.57
4/30/2016
5,602,144
5,347,916
5,544,386
Colfax Corporation
9/12/2018
500,000
495,000
Consolidated Container Company LLC
Loan (First Lien)
2.50
3/28/2014
5,210,092
4,884,782
4,828,036
Contec, LLC
9.00
7/28/2014
2,644,318
2,614,917
1,123,835
Covanta Energy Corporation
Funded Letter of Credit
1.77
2/10/2014
877,007
858,874
855,994
1,702,627
1,667,261
1,661,833
CPI International Acquisition, Inc. (f/k/a Catalyst Holdings, Inc.)
2/13/2017
4,940,942
4,900,469
CRC Health Corporation
Term B-2 Loan
4.87
11/16/2015
1,991,877
1,889,653
1,852,446
CSC Holdings, LLC (fka CSC Holdings Inc (Cablevision))
Term A-3 Loan
3/31/2015
1,401,754
1,395,623
1,331,667
Culligan International Company
Dollar Loan
11/24/2012
2,399,497
2,355,174
1,639,649
DaVita Inc.
10/20/2016
3,977,520
Del Monte Foods Company
4.50
3/8/2018
1,496,250
1,492,900
1,415,198
Dollar General Corporation
3.04
7/7/2014
5,378,602
5,176,755
5,367,199
DS Waters of America, Inc.
10/29/2012
491,776
484,668
450,796
DynCorp International Inc.
7/7/2016
819,776
807,175
801,585
Education Management LLC
Tranche C-2 Term Loan
4.38
6/1/2016
3,978,573
3,701,347
3,624,759
eInstruction Corporation
4.51
7/2/2013
3,013,426
2,915,952
2,712,083
Electrical Components International, Inc.
Synthetic Revolving Loan
6.75
2/4/2016
117,647
116,169
110,588
2/4/2017
1,868,235
1,844,005
1,756,141
Emdeon Inc.
11/2/2018
485,164
501,425
Federal-Mogul Corporation
2.19
12/29/2014
2,623,102
2,469,031
2,397,332
Tranche C Term Loan
12/28/2015
1,338,317
1,255,268
1,223,128
First Data Corporation
2018 Dollar Term Loan
4.26
3/26/2018
2,290,451
2,198,651
1,904,899
Non Extending B-1 Term Loan
9/24/2014
1,971,336
1,930,273
1,741,813
Non Extending B-2 Term Loan
990,052
970,198
874,780
FleetPride Corporation
12/6/2017
980,000
FR Acquisitions Holding Corporation (Luxembourg), S.A.R.L.
Facility B (Dollar)
12/18/2015
1,295,106
1,291,789
1,193,117
Facility C (Dollar)
5.37
12/20/2016
1,291,432
1,199,592
Freescale Semiconductor, Inc.
Extended Maturity Term Loan
12/1/2016
1,534,348
1,465,031
1,440,370
Fresenius Medical Care AG & Co., KGaA/Fresenius Medical Care Holdings, Inc.
1.74
3/31/2013
4,235,924
4,213,867
4,185,644
FTD Group, Inc.
6/11/2018
3,992,500
3,951,394
3,912,650
General Nutrition Centers, Inc.
3/2/2018
3,750,000
3,616,100
3,660,938
Goodyear Tire & Rubber Company, The
Loan (Second Lien)
1.93
4/30/2014
5,700,000
5,297,925
5,438,769
Graphic Packaging International, Inc.
2.39
5/16/2014
3,045,465
2,895,636
3,012,361
Grosvenor Capital Management Holdings, LLLP
12/5/2016
3,500,961
3,383,604
3,343,418
GSI Holdings L.L.C.
8/1/2014
5,637,880
5,556,899
5,440,554
Hanger Orthopedic Group, Inc.
4.01
3,970,000
3,983,002
3,811,200
HCA Inc.
Tranche B-3 Term Loan
5/1/2018
5,734,690
5,369,151
5,407,010
Health Management Associates, Inc.
11/16/2018
2,970,000
2,985,000
Hilsinger Company, The
12/31/2013
1,221,687
1,204,358
1,075,084
Hoffmaster Group, Inc.
Incremental Facility 2011
3/31/2016
1,975,000
6/2/2016
3,657,500
3,597,083
3,620,925
Hunter Defense Technologies, Inc.
8/22/2014
4,471,763
4,393,191
4,024,587
Hygenic Corporation, The
4/30/2013
1,567,150
1,535,181
1,441,778
Infor Enterprise Solutions Holdings, Inc. (fka Magellan Holdings, Inc.)(Infor Global Solutions)
Extended Delayed Draw Term Loan (First Lien)
6.01
7/28/2015
1,314,907
1,223,594
1,228,781
Extended Initial U.S. Term Loan (First Lien)
2,520,239
2,344,967
2,355,163
Insight Equity A.P. X, LP
4.53
12/18/2012
1,380,065
1,376,364
1,242,059
Intrapac Corporation/Corona Holdco
1st Lien Term Loan
3.93
5/18/2012
2,801,054
2,774,004
2,097,289
Inventiv Health, Inc. (fka Ventive Health, Inc)
Consolidated Term Loan
6.50
8/4/2016
497,085
485,488
J. Crew Group, Inc.
Loan
3/7/2018
995,000
907,191
Kalispel Tribal Economic Authority
2/25/2017
3,912,931
3,844,540
3,599,897
Key Safety Systems, Inc.
3/8/2014
3,832,103
3,587,546
3,531,934
Kinetek Industries, Inc.
Term B-1 Loan
2.87
11/10/2013
1,170,963
1,125,835
1,059,722
118,763
114,236
107,481
Kinetic Concepts, Inc.
Dollar Term B-1 Loan
5/4/2018
482,677
500,940
Leslie’s Poolmart, Inc.
3,975,926
3,827,755
National CineMedia, LLC
1.84
2/13/2015
2,655,172
2,565,789
2,546,310
Nielsen Finance LLC
Class A Dollar Term Loan
2.25
8/9/2013
4,542,571
4,467,048
4,457,398
Novelis, Inc.
3/10/2017
4,004,882
3,888,933
Novell, Inc. (fka Attachmate Corporation, NetIQ Corporation)
4/27/2017
4,973,752
4,857,500
NPC International, Inc.
2.01
5/3/2013
4,317,595
4,215,659
4,279,816
NRG Energy, Inc.
7/1/2018
3,960,762
3,952,614
NuSil Technology LLC.
4/7/2017
932,203
904,237
Onex Carestream Finance LP
4,974,758
4,952,991
4,394,055
OpenLink International, Inc.
7.75
10/30/2017
980,274
997,500
1.58
10/6/2016
446,667
247,498
241,200
Pelican Products, Inc.
3/7/2017
2,947,725
Penn National Gaming, Inc.
Term A Facility
1.79
7/14/2016
2,962,500
2,879,481
2,858,813
7/16/2018
995,142
997,660
Pharmaceutical Product Development, Inc. (Jaguar Holdings, LLC)
12/5/2018
1,970,000
1,971,420
Pharmaceutical Research Associates Group B.V.
Dutch Dollar Term Loan
3.60
12/15/2014
921,177
864,045
875,118
Physician Oncology Services, LP
Delayed Draw Term Loan
1/31/2017
51,020
50,575
47,704
Effective Date Term Loan
419,961
416,291
392,663
Pinnacle Foods Finance LLC
2.78
4/2/2014
4,808,633
4,694,994
4,706,450
PolyOne Corporation
Term Loan B
11/1/2017
499,375
PRA International
U.S. Term Loan
1,286,657
1,206,857
1,222,324
Pre-Paid Legal Services, Inc.
Tranche A Term Loan
12/31/2016
2,939,024
2,898,030
2,821,463
23
Prestige Brands, Inc.
4.78
3/24/2016
3,067,408
3,062,836
3,052,071
Pro Mach, Inc.
7/6/2017
1,995,000
1,976,226
1,925,175
Quintiles Transnational Corp.
6/8/2018
3,952,817
3,870,300
Ranpak Corp.
USD Term Loan (First Lien)
4/20/2017
2,751,305
2,738,881
2,634,374
Rexnord LLC/RBS Global, Inc.
Tranche B-2 Term B Loan
2.56
7/19/2013
1,611,914
1,563,575
1,568,924
Reynolds Group Holdings Inc.
2/9/2018
1,990,000
1,941,623
8/9/2018
1,980,883
1,951,660
Royal Adhesives and Sealants, LLC
Term A Loan
11/29/2015
5,553,571
5,492,914
5,472,319
RPI Finance Trust
6.75 Year Term Loan
5,486,250
5,460,013
5,447,407
Savers, Inc.
3/4/2017
497,500
490,038
Scitor Corporation
2/15/2017
496,250
494,094
471,438
Scotsman Industries, Inc.
5.75
1,877,963
1,871,489
1,849,793
Seminole Tribe of Florida
Term B-1 Delay Draw Loan
3/5/2014
617,981
606,116
582,447
Term B-2 Delay Draw Loan
2,236,226
2,193,282
2,107,643
Term B-3 Delay Draw Loan
1,185,867
1,156,851
1,117,680
Sensus USA Inc. (fka Sensus Metering Systems)
5/9/2017
1,980,944
1,950,200
SI Organization, Inc., The
New Tranche B Term Loan
11/22/2016
3,937,044
3,791,350
SRA International Inc.
7/20/2018
3,931,429
3,772,754
3,626,743
SRAM, LLC
4.76
6/7/2018
3,930,308
3,891,916
3,861,527
SunCoke Energy, Inc.
7/26/2018
3,996,250
3,973,031
3,906,334
SunGard Data Systems Inc (Solar Capital Corp.)
Incremental Term B Loan
2/28/2014
Tranche A U.S. Term Loan
2.00
197,048
193,159
192,812
Tranche B U.S. Term Loan
3.98
2/28/2016
4,557,119
4,437,660
4,420,405
Sunquest Information Systems, Inc. (Misys Hospital Systems, Inc.)
12/16/2016
982,429
981,737
11.00
12/31/2015
338,100
326,876
151,865
Targus Group International, Inc.
5/24/2016
2,938,224
2,805,469
TDG Holding Company (fka Dwyer Acquisition, Inc.)
12/23/2015
3,508,727
3,464,505
3,456,096
Team Health, Inc.
6/29/2018
4,488,750
4,467,542
4,309,200
Telcordia Technologies, Inc.
3,458,616
3,452,199
3,415,383
Texas Competitive Electric Holdings Company, LLC (TXU)
2014 Term Loan (Non-Extending)
3.76
10/10/2014
5,580,862
5,486,179
4,016,714
TransDigm Inc.
2/14/2017
3,998,852
4,012,903
3,956,024
TransFirst Holdings, Inc.
6/15/2014
2,393,543
2,352,949
2,182,624
Tricorbraun Inc. (fka Kranson Industries, Inc.)
7/31/2013
1,204,015
1,170,621
1,164,885
U.S. Security Associates Holdings, Inc.
1.50
7/28/2017
163,000
(1,541
837,000
829,089
819,214
U.S. Silica Company
6/8/2017
1,985,805
1,975,050
Univar Inc.
6/30/2017
3,974,987
3,973,806
3,829,662
UPC Financing Partnership
Facility AB
12/31/2017
970,228
979,060
USI Holdings Corporation
2.76
5/5/2014
4,794,730
4,686,233
4,578,967
Vantiv, LLC (fka Fifth Third Processing Solutions, LLC)
Term B-1 Loan (First Lien)
11/3/2016
3,989,975
3,999,331
3,952,589
Verint Systems Inc.
Term Loan 2011
10/27/2017
1,980,914
1,958,916
Visant Corporation (fka Jostens)
Tranche B Term Loan (2011)
12/22/2016
3,729,339
Weight Watchers International, Inc.
1.63
1/26/2014
1,232,435
1,222,301
1,203,941
Term D Loan
2.63
6/30/2016
2,735,151
2,689,001
2,692,428
Wendy’s/Arby’s Restaurants, LLC
5/24/2017
1,125,752
1,121,341
1,121,182
Wenner Media LLC
10/2/2013
2,664,829
2,608,813
2,584,884
Wil Research Laboratories, LLC
9/26/2013
1,813,134
1,718,396
1,668,083
WireCo WorldGroup Inc.
1,997,963
1,968,723
1,958,004
Yankee Candle Company, Inc.
2.26
2/6/2014
2,537,336
2,404,603
2,469,462
Yell Group Plc
Facility B1 - YB (USA) LLC (11/2009)
7/31/2014
3,139,856
3,088,153
800,663
ALM 2010-1A
Floating - 05/2020 - B - 00162VAE5
Other/Structured Finance Securities
5/20/2020
3,708,011
3,657,600
BABSN 2007-1A
Floating - 01/2021 - D1 - 05617AAA9
3.65
1/18/2021
1,500,000
1,229,601
1,050,000
GALE 2007-3A
Floating - 04/2021 - E - 363205AA3
3.91
4/19/2021
3,292,419
2,800,000
KATO 2006-9A
Floating - 01/2019 - B2L - 486010AA9
3.92
1/25/2019
4,199,605
STCLO 2007-6A
Floating - 04/2021 - D- 86176YAG7
4/17/2021
4,052,528
398,880,826
24
M/C Acquisition Corp.
378,434
68,806
720,549
2,881,566
ABP Corporation (Au Bon Pain)
8.50
2/28/2013
3,678,254
3,663,509
3,641,471
504,625
Term Loan Retired 03/01/2011
7/28/2013
1,904,344
1,860,734
1,901,926
3.07
253,920
236,167
236,570
3.06
4,652,900
4,462,578
4,334,967
Tranche B-1 Term Loan Retired 05/09/2011
4.31
8/15/2014
3,896,513
3,839,728
3,906,254
Tranche B-2 Term Loan Retired 05/09/2011
4.81
600,000
599,258
598,500
617,575
593,524
571,257
Affordable Care, Inc.
985,000
APS Healthcare, Inc.
3.52
3/30/2013
1,848,940
1,808,135
1,802,717
3.27
7/3/2014
5,925,000
5,811,967
5,828,719
509,033
1,990,316
2,018,760
Axcan Intermediate Holdings Inc.
3.67
1,333,333
1,323,393
1,346,453
Term Loan Retired 03/11/2011
989,362
975,102
1,001,422
2,968,085
2,989,634
3,004,266
Bankruptcy Management Solutions, Inc.
8/20/2014
3,956,481
3,544,161
1,819,981
7.61
4/21/2015
5,077,648
5,042,065
5,090,342
California Family Health LLC (fka CFF Acquisition LLC)
7/31/2015
2,814,935
2,808,774
2,800,860
CCM Merger Inc. (Motor City Casino)
Term B Loan Retired 03/01/2011
7/13/2012
3,390,358
3,272,522
Dollar Term B Loan (Non-Extended) Retired 05/06/2011
1.80
682,863
669,206
684,495
3,548,125
3,530,135
2,970,945
3,027,510
3.81
1,360,448
1,341,805
1,367,930
139,402
135,936
138,646
2,705,964
2,640,759
2,691,298
1,861,233
1,845,123
1,870,539
3.54
5,644,908
5,345,039
5,690,802
Citco III Limited
B Term Loan
4.46
6/30/2014
3,625,898
3,544,965
3,607,768
5,286,113
4,848,098
5,173,783
Consolidated Precision Products Corp.
4/17/2014
1,421,747
1,406,721
1,393,312
2,658,068
2,620,135
2,409,991
Continental Alloys & Services, Inc.
Term Facility
6/15/2012
3,003,802
2,886,239
3,001,308
1.70
852,656
873,876
1.81
1,715,999
1,668,245
1,709,873
4,975,137
5,012,500
4.80
1,877,839
1,992,500
2.52
2,418,342
2,339,419
2,106,376
DeCrane Aerospace, Inc. (fka DeCrane Aircraft Holdings, Inc.)
Second Lien Term Loan
2/21/2014
969,493
924,594
664,103
1,511,715
3.03
5,118,264
5,389,036
2.57
495,888
482,802
485,350
979,658
1,005,809
7,112,226
6,533,750
6,997,790
3,036,981
2,892,088
2,794,023
1.40
115,903
117,941
1,882,353
1,854,389
1,887,059
Emdeon Business Services LLC
2.27
11/16/2013
4,877,709
4,730,606
4,855,369
2.20
2,643,542
2,449,987
2,573,330
1,348,746
1,249,431
1,312,923
3,727,178
3,628,773
3,555,728
1,868,259
1,820,772
1,783,123
FleetCor Technologies Operating Company, LLC
Tranche 1 Term Loan
4,461,805
4,354,515
Tranche 2 Term Loan
901,783
880,096
1,291,172
1,246,540
5.30
1,290,884
1,253,015
1,549,402
1,468,869
1,549,216
1.68
4,269,542
4,234,546
4,255,069
Georgia-Pacific LLC
2.30
12/23/2012
2,876,959
2,765,714
2,878,887
Term Loan C
3.55
12/23/2014
2,520,062
2,390,204
2,529,210
1.96
5,172,419
5,631,600
25
Graham Packaging Company, L.P.
C Term Loan
4/5/2014
4,586,342
4,605,467
3,317,758
3,102,031
3,315,701
3,548,952
3,412,119
3,531,207
3.32
5,794,414
5,687,799
5,664,039
4,014,504
4,039,160
2.55
11/18/2013
5,470,319
5,720,353
1,438,859
1,411,074
1,294,973
3,728,750
3,656,667
3,733,411
3.56
4,600,368
4,496,163
4,493,042
2.80
1,731,548
1,674,176
1,614,668
6.02
1,329,765
1,218,397
1,311,813
2,548,716
2,334,952
2,514,308
4.47
1,568,246
1,561,020
1,411,421
3.80
3,813,798
3,717,037
2,855,581
166,667
167,362
1,390
1,002,190
3,920,037
3,863,090
3,536,408
3,752,026
3.94
1,285,429
1,221,491
1,219,011
130,372
123,957
123,636
Lender Processing Services, Inc.
7/2/2014
633,750
630,214
631,373
Tranche B Term Loan (Expired 3.1.2011)
4,006,665
4,040,000
1.00
12/31/2012
1,981,257
297,188
Matthew Warren Industries, Inc.
11/1/2013
1,396,992
1,332,049
1,131,564
National Diversified Sales, Inc.
8/9/2011
1,260,509
1,224,767
1,247,904
4,924,279
4,806,327
4,936,590
Term Loan (Old)
12/17/2016
4,039,222
4,056,800
3,960,000
2.04
4,161,647
4,309,521
Extended Maturity Credit-Linked Deposit
8/31/2015
1,003,705
1,007,000
Original Maturity Credit-Linked Deposit
2.05
2/1/2013
739,113
723,964
738,085
Original Maturity Term Loan
2,880,954
2,823,408
2,876,950
2/18/2015
3,780,000
3,749,885
Nuveen Investments, Inc.
Non-Extended First-Lien Term Loan
3.30
11/13/2014
2,494,682
2,450,410
2,429,197
Nyco Holdings 3 ApS (Nycomed)
Facility B2
1,766,354
1,687,712
1,730,391
Facility C2
12/29/2015
1,765,817
1,679,620
1,738,694
4,975,000
Term Loan Old
11/30/2016
2,971,226
3,020,010
928,355
856,513
900,504
(510)
(51,020)
448,980
444,490
4,818,867
4,668,244
4,808,555
1,187,087
4,167,500
4,152,819
4,189,629
QA Direct Holdings, LLC
Term Loan Retired 03/23/2011
8.25
8/10/2014
1,756,006
1,746,771
1,747,226
QCE, LLC (Quiznos)
5.01
5/5/2013
2,713,190
2,642,924
2,579,457
Term B Loan (First Lien)
2.31
1,350,372
1,341,560
1,346,996
US Dollar Term Loan B (First Lien) Retired 04/20/2011
4.77
12/27/2013
2,729,247
2,702,688
2,592,785
Repconstrickland, Inc.
10.00
2/19/2014
2,982,729
2,963,648
2,744,111
1,624,606
1,553,407
1,614,940
4,925,515
Royalty Pharma Finance Trust
4/16/2013
4,111,216
4,104,705
4,126,633
497,514
503,540
5.51
942,875
934,736
946,411
623,301
607,432
619,592
2,254,231
2,196,806
2,240,818
1,418,608
1,377,771
1,410,167
3,961,772
4,030,000
Specialized Technology Resources, Inc.
6/13/2014
3,525,541
3,444,179
3,283,160
503,325
191,855
196,124
4,416,466
4,579,905
985,480
1,005,000
359,815
347,869
238,604
Survey Sampling International, LLC
10.40
1,775,683
1,766,073
1,154,194
Targus Holdings, Inc.
Tranche B Term Loan (First Lien)
8.75
11/22/2012
2,789,590
2,701,112
2,768,668
3,940,238
3,940,000
Team Finance LLC (a.k.a Team Health Holdings, LLC)
11/23/2012
5,570,899
5,369,893
5,543,045
3,961,377
3,982,426
Initial Tranche B-2 Term Loan
3.79
5,805,000
5,740,180
4,834,868
2,412,500
2,359,447
2,320,029
1,223,256
1,173,926
1,180,442
Triumph Group Inc.
Loan Retired 04/05/2011
6/16/2016
1,243,750
1,238,248
1,246,088
U.S. Security Holdings, Inc.
Acquisition Term Loan
4.04
5/8/2013
106,289
102,005
105,224
564,358
541,608
561,536
5/9/2016
1,343,250
1,337,430
1,344,929
26
United States Infrastructure Corporation (fka Stripe Acquisition, Inc.)
5/13/2015
1,393,000
1,381,246
1,394,741
2.77
4,832,287
4,689,161
4,820,206
Weasler Engineering, Inc.
6.76
9/30/2013
1,195,707
1,023,493
1,171,792
1,242,139
1,228,356
1,239,034
2,755,924
2,701,780
2,765,377
1,194,000
1,188,678
1,202,585
2,830,535
2,750,229
2,717,314
Wesco Aircraft Hardware Corp.
Loan (Second Lien) Retired 04/07/2011
1,720,000
1,655,183
1,721,428
1,828,419
1,693,356
1,609,009
4,687,066
4,582,305
Worldwide Express Operations, LLC
6/30/2013
3,844,761
3,075,809
2,358,862
2,530,409
3,216,223
3,148,340
1,485,895
2.58
3,682,050
1,207,311
3,235,640
4,115,337
8.600% - 01/2020-6412BAD3
Unsecured Notes
8.60
1/14/2020
1,028,572
3,260,000
743,452
3.90
3,976,453
13.000% - 03/2013 - 290608AA6
17.00
2,040,000
2,006,316
1,500,012
402,031,794
Note 5. Agreements
On July 30, 2010, the Company entered into an investment advisory and management agreement (the “Management Agreement”) with our Manager. The initial term of the Management Agreement is two years, with automatic, one-year renewals at the end of each year subject to certain approvals by our board of directors and/or our stockholders. Pursuant to the Management Agreement, our Manager implements our business strategy on a day-to-day basis and performs certain services for us, subject to oversight by our board of directors. Our Manager is responsible for, among other duties, determining investment criteria, sourcing, analyzing and executing investment transactions, asset sales, financings and performing asset management duties. Under the Management Agreement, we have agreed to pay our Manager a management fee for investment advisory and management services consisting of a base management fee and an incentive fee.
The base management fee of 1.75% is calculated based on the average value of our gross assets (other than cash or cash equivalents, but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters, and appropriately adjusted for any share issuances or repurchases during the applicable fiscal quarter.
The incentive fee consists of the following two parts:
The first, payable quarterly in arrears, equals 20% of our pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, that exceeds a 1.875% quarterly (7.5% annualized) hurdle rate measured as of the end of each fiscal quarter, subject to a “catch-up” provision. Under this provision, in any fiscal quarter, our Manager receives no incentive fee unless our pre-incentive fee net investment income exceeds the hurdle rate of 1.875%. Our Manager will receive 100% of pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter (9.376% annualized); and 20% of the amount of the our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter (9.376% annualized).
The second part of the incentive fee is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Management Agreement) and equals 20% of our “incentive fee capital gains,” which equals our realized capital gains on a cumulative basis from May 31, 2010 through the end of the year, if any, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis from May 31, 2010, less the aggregate amount of any previously paid capital gain incentive fee. Importantly, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and our Manager will be entitled to 20% of incentive fee capital gains that arise after May 31, 2010. In addition, for the purpose of the “incentive fee capital gains” calculations, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 will equal the fair value of such investments as of such date.
27
The terms of the Management Agreement with our Manager is substantially similar to the terms (i.e., a quarterly base management fee of 1.75% of the average value of our total assets—other than cash or cash equivalents but including assets purchased with borrowed funds—at the end of the two most recently completed fiscal quarters, and an incentive fee) of the investment advisory and management agreement we had entered into with GSCP (NJ), L.P., our former investment adviser, except for the following material distinctions in the fee terms:
· The capital gains portion of the incentive fee was reset with respect to gains and losses from May 31, 2010, and therefore losses and gains incurred prior to such time will not be taken into account when calculating the capital gains fee payable to our Manager and, as a result, our Manager will be entitled to 20% of realized gains net of unrealized losses and realized losses that arise after May 31, 2010. In addition, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 equal the fair value of such investment as of such date. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P., the capital gains fee was calculated from March 21, 2007, and the gains were substantially outweighed by losses.
· Under the “catch up” provision, 100% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income that exceeds 1.875% (7.5% annualized) but is less than or equal to 2.344% in any fiscal quarter is payable to our Manager. This will enable our Manager to receive 20% of all net investment income as such amount approaches 2.344% in any quarter, and our Manager will receive 20% of any additional net investment income. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P. only received 20% of the excess net investment income over 1.875%.
· We will no longer have deferral rights regarding incentive fees in the event that the distributions to stockholders and change in net assets is less than 7.5% for the preceding four fiscal quarters.
For the three months ended November 30, 2011 and November 30, 2010, we accrued $0.4 and $0.4 million in base management fees, respectively. For the three months ended November 30, 2011 and November 30, 2010, we accrued $0.3 and $0.3 million in incentive fees related to pre-incentive fee net investment income, respectively. For the three months ended November 30, 2011 and November 30, 2010, we accrued $0.9 and $0.9 million in incentive management fees related to capital gains, respectively. For the nine months ended November 30, 2011 and November 30, 2010, we accrued $1.2 million and $1.3 million in base management fees, respectively. For the nine months ended November 30, 2011, we accrued $0.3 million in incentive fees related to pre-incentive fee net investment income. For the nine months ended November 30, 2010, we accrued $0.3 million in incentive fees related to pre-incentive fee net investment income and recorded a $2.6 million reversal in previously recorded deferred incentive management fees related to net investment income as a result of the agreement of our former investment adviser, GSCP (NJ), L.P., to waive such amount in connection with the recapitalization transaction described in “Note. 13 Recapitalization Transaction” below. For the nine months ended November 30, 2011 and November 30, 2010, we accrued $0.5 and $0.9 million in incentive management fees related to capital gains, respectively. These accruals and the accruals related to the capital gains incentive fees for the three and nine months ended November 30, 2011 and 2010 were calculated using both realized and unrealized capital gains for the period. The actual incentive fee related to capital gains will be determined and payable in arrears at the end of the fiscal year and will include only realized capital gains for the period. As of November 30, 2011, $0.4 million of base management fees and $2.1 million of incentive fees were accrued and included in management and incentive fees payable in the accompanying consolidated statement of assets and liabilities. As of February 28, 2011, $0.7 million of base management fees and $1.5 million of incentive fees were accrued and included in management and incentive fees payable in the accompanying consolidated statement of assets and liabilities.
On July 30, 2010, the Company entered into a separate administration agreement (the “Administration Agreement”) with our Manager, pursuant to which our Manager, as our administrator, has agreed to furnish us with the facilities and administrative services necessary to conduct our day-to-day operations and provide managerial assistance on our behalf to those portfolio companies to which we are required to provide such assistance. The initial term of the Administration Agreement is two years, with automatic, one-year renewals at the end of each year subject to certain approvals by our board of directors and/or our stockholders. The amount payable to our Manager as administrator is capped at $1 million for the initial two year term of the administration agreement.
The amount payable to GSCP (NJ), L.P., our former investment adviser and administrator, as administrator was capped to the effect that such amount, together with our other operating expenses, could not exceed an amount equal to 1.5% per annum of our net assets attributable to common stock. In addition, for the one-year term of the administration agreement expiring on March 21, 2011, GSCP (NJ), L.P. had agreed to waive our reimbursement obligation under the administration agreement until our total assets exceeded $500 million.
For the three months ended November 30, 2011 and November 30, 2010, we recognized $0.3 million and $0.2 million in administrator expenses for the periods, pertaining to bookkeeping, record keeping and other administrative services provided to us in addition to our allocable portion of rent and other overhead related expenses. For the nine months ended November 30, 2011 and November 30, 2010, we recognized $0.7 million and $0.6 million in administrator expenses for the periods, pertaining to
28
bookkeeping, record keeping and other administrative services provided to us in addition to our allocable portion of rent and other overhead related expenses. As of November 30, 2011, $0.3 million of administrator expenses were accrued and included in due to manager in the accompanying consolidated statement of assets and liabilities.
Note 6. Borrowings
As a BDC, we are only allowed to employ leverage to the extent that our asset coverage, as defined in the 1940 Act, equals at least 200% after giving effect to such leverage. The amount of leverage that we employ at any time depends on our assessment of the market and other factors at the time of any proposed borrowing.
On April 11, 2007, we entered into a $100.0 million revolving securitized credit facility (the “Revolving Facility”). On May 1, 2007, we entered into a $25.7 million term securitized credit facility (the “Term Facility” and, together with the Revolving Facility, the “Facilities”), which was fully drawn at closing. In December 2007, we consolidated the Facilities by using a draw under the Revolving Facility to repay the Term Facility. In response to the market wide decline in financial asset prices, which negatively affected the value of our portfolio, we terminated the revolving period of the Revolving Facility effective January 14, 2009 and commenced a two-year amortization period during which all principal proceeds from the collateral was used to repay outstanding borrowings. A significant percentage of our total assets had been pledged under the Revolving Facility to secure our obligations thereunder. Under the Revolving Facility, funds were borrowed from or through certain lenders and interest was payable monthly at the greater of the commercial paper rate and our lender’s prime rate plus 4.00% plus a default rate of 2.00% or, if the commercial paper market was unavailable, the greater of the prevailing LIBOR rates and our lender’s prime rate plus 6.00% plus a default rate of 3.00%.
In March 2009, we amended the Revolving Facility to increase the portion of the portfolio that could be invested in “CCC” rated investments in return for an increased interest rate and expedited amortization. As a result of these transactions, we expected to have additional cushion under our borrowing base under the Revolving Facility that would allow us to better manage our capital in times of declining asset prices and market dislocation.
On July 30, 2009, we exceeded the permissible borrowing limit under the Revolving Facility for 30 consecutive days, resulting in an event of default under the Revolving Facility. As a result of this event of default, our lender had the right to accelerate repayment of the outstanding indebtedness under the Revolving Facility and to foreclose and liquidate the collateral pledged thereunder. Acceleration of the outstanding indebtedness and/or liquidation of the collateral could have had a material adverse effect on our liquidity, financial condition and operations.
On July 30, 2010, we used the net proceeds from (i) the stock purchase transaction and (ii) a portion of the funds available to us under the $40 million senior secured revolving credit facility (the “Replacement Facility”) with Madison Capital Funding LLC, in each case, described in “Note 13. Recapitalization Transaction” below, to pay the full amount of principal and accrued interest, including default interest, outstanding under the Revolving Facility. As a result, the Revolving Facility was terminated in connection therewith. Substantially all of our assets have been pledged under the Replacement Facility to secure our obligations thereunder, including the subordinated notes issued by Saratoga CLO and the related collateral management agreement. As of November 30, 2011, there was no outstanding balance under the Replacement Facility and the Company was in compliance with all of the limitations and requirements of the Replacement Facility. $2.0 million of financing costs related to the Replacement Facility have been capitalized and are being amortized over the three year term of the facility. For the three months ended November 30, 2011 and November 30, 2010, we recorded $0.1 million and $0.4 million of interest expense, respectively, related to the Replacement Facility. For the three months ended November 30, 2011 and November 30, 2010, we recorded $0.2 million and $0.2 million of amortization of deferred financing costs, respectively, related to the Replacement Facility. The interest rate during the three months ended November 30, 2011 on the unfunded commitment was 0.75%. The interest rate during the three months ended November 30, 2010 on the outstanding borrowings was 7.50%. The interest rate during the nine months ended November 30, 2011 on the outstanding borrowings was 7.50%. The interest rates during the nine months ended November 30, 2010 on the outstanding borrowings ranged from 7.50% to 9.25%. For the nine months ended November 30, 2011 and November 30, 2010, we recorded $0.5 million and $2.0 million of interest expense, respectively, related to the Replacement Facility. For the nine months ended November 30, 2011 and November 30, 2010, we recorded $0.5 million and $0.2 million of amortization of deferred financing costs, respectively, related to the Replacement Facility.
29
The Replacement Facility contains limitations as to how borrowed funds may be used, such as restrictions on industry concentrations, asset size, weighted average life, currency denomination and collateral interests. The Replacement Facility also includes certain requirements relating to portfolio performance, the violation of which could result in the limit of further advances and, in some cases, result in an event of default, allowing the lenders to accelerate repayment of amounts owed thereunder. The Replacement Facility has an eight year term, consisting of a three year period (the “Revolving Period”), under which the Company may make and repay borrowings, and a final maturity five years from the end of the Revolving Period. Availability on the Replacement Facility will be subject to a borrowing base calculation, based on, among other things, applicable advance rates (which vary from 50% to 75% of par or fair value depending on the type of loan asset) and the value of certain “eligible” loan assets included as part of the Borrowing Base. Funds may be borrowed at the greater of the prevailing LIBOR rate and 2.00%, plus an applicable margin of 5.50%. At the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 3.00%, and the applicable margin over such alternative base rate is 4.50%. In addition, the Company will pay the lenders a commitment fee of 0.75% per year on the unused amount of the Replacement Facility for the duration of the Revolving Period.
Our borrowing base under the Replacement Facility was $27.3 million at November 30, 2011. For purposes of determining the borrowing base, most assets are assigned the values set forth in our most recent annual report on Form 10-K or quarterly report on Form 10-Q filed with the SEC. Accordingly, the November 30, 2011 borrowing base relies upon the valuations set forth in the quarterly report on Form 10-Q for the quarter ended August 31, 2011. The valuations presented in this quarterly report on Form 10-Q will not be incorporated into the borrowing base until after this quarterly report on Form 10-Q is filed with the SEC.
At any time prior to the second anniversary of the closing of the Replacement Facility and subject to certain conditions, we may request an increase in the Replacement Facility amount of up to $60 million for a combined aggregate Replacement Facility amount of $100 million.
Note 7. Interest Rate Cap Agreements
In April and May 2007, pursuant to the requirements of the Facilities, we, through a wholly owned subsidiary, entered into interest rate cap agreements with Deutsche Bank AG with notional amounts of $34.0 million and $60.9 million at costs of $75,000, and $44,000, respectively. In May 2007, we increased the notional amount under the $34.0 million agreement from $34.0 million to $40.0 million for an additional cost of $12,000. The agreements expire in February 2014 and November 2013, respectively. These interest rate caps are treated as free-standing derivatives under ASC 815 and are presented at their fair value on the consolidated statements of assets and liabilities and the changes in their fair value are included on the consolidated statements of operations.
The agreements provide for a payment to us in the event LIBOR exceeds 8%, mitigating our exposure to increases in LIBOR. With respect to calculating the payments under these agreements, the notional amount is determined based on a pre-determined schedule set forth in the respective agreements which provides for a reduction in the notional amount at specified dates until the maturity of the agreements. As of November 30, 2011, we did not receive any such payments as LIBOR has not exceeded 8%. As of November 30, 2011, the total notional amount outstanding for the interest rate caps was $32.4 million with an aggregate fair value of $1,157, which is recorded in outstanding interest cap at fair value on our consolidated statements of assets and liabilities. For the three months ended November 30, 2011 and November 30, 2010, we recorded $166 of unrealized appreciation and $1,366 of unrealized depreciation, respectively, on derivatives in our consolidated statements of operations related to the change in the fair value of the interest rate cap agreements. For the nine months ended November 30, 2011 and November 30, 2010, we recorded $15,108 and $19,797 of unrealized depreciation, respectively, on derivatives in our consolidated statements of operations related to the change in the fair value of the interest rate cap agreements.
The table below summarizes our interest rate cap agreements as of November 30, 2011 (dollars in thousands):
Instrument
Type
Interest Rate
Interest Rate Cap
Free Standing Derivative
22,041
Feb 2014
10,332
Nov 2013
Net fair value
The table below summarizes our interest rate cap agreements as of February 28, 2011 (dollars in thousands):
29,388
23,966
30
Note 8. Directors Fees
The independent directors receive an annual fee of $40,000. They also receive $2,500 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each board meeting and receive $1,000 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each committee meeting. In addition, the chairman of the Audit Committee receives an annual fee of $5,000 and the chairman of each other committee receives an annual fee of $2,000 for their additional services in these capacities. In addition, we have purchased directors’ and officers’ liability insurance on behalf of our directors and officers. Independent directors have the option to receive their directors’ fees in the form of our common stock issued at a price per share equal to the greater of net asset value or the market price at the time of payment. No compensation is paid to directors who are “interested persons” of the Company (as such term is defined in the 1940 Act). For the three months ended November 30, 2011 and November 30, 2010, we accrued $0.05 and $0.05 million for directors’ fees expense, respectively. For the nine months ended November 30, 2011 and November 30, 2010, we accrued $0.2 and $0.3 million for directors’ fees expense, respectively. As of November 30, 2011, $0.05 million in directors’ fees expense were unpaid and included in accounts payable and accrued expenses in the consolidated statements of assets and liabilities. As of November 30, 2011, we had not issued any common stock to our directors as compensation for their services.
Note 9. Stockholders’ Equity
On May 16, 2006, GSC Group, Inc. capitalized the LLC, by contributing $1,000 in exchange for 6.7 shares, constituting all of the issued and outstanding shares of the LLC.
On March 20, 2007, the Company issued 95,995.5 and 8,136.2 shares of common stock, priced at $150.00 per share, to GSC Group and certain individual employees of GSC Group, respectively, in exchange for the general partnership interest and a limited partnership interest in GSC Partners CDO III GP, LP, collectively valued at $15.6 million. At this time, the 6.7 shares owned by GSC Group in the LLC were exchanged for 6.7 shares of the Company.
On March 28, 2007, the Company completed its IPO of 725,000 shares of common stock, priced at $150.00 per share, before underwriting discounts and commissions. Total proceeds received from the IPO, net of $7.1 million in underwriter’s discount and commissions, and $1.0 million in offering costs, were $100.7 million.
On November 13, 2009, we declared a dividend of $18.25 per share payable on December 31, 2009. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.1 million or $2.50 per share. Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872.5 of newly issued shares of common stock.
On July 30, 2010, our Manager and its affiliates purchased 986,842 shares of common stock at $15.20 per share. Total proceeds received from this sale were $15.0 million. See “Note 13. Recapitalization Transaction.”
On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was $230. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.
On November 12, 2010, we declared a dividend of $4.40 per share payable on December 29, 2010. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $1.2 million or $0.44 per share. Based on shareholder elections, the dividend consisted of approximately $1.2 million in cash and 596,235 shares of common stock.
On November 15, 2011, we declared a dividend of $3.00 per share payable on December 30, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.0 million or $0.60 per share. Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 599,584 shares of common stock.
Note 10. Earnings Per Share
In accordance with the provisions of FASB ASC 260, “Earnings per Share” (“ASC 260”), basic earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.
31
The following information sets forth the computation of the weighted average basic and diluted net increase in net assets per share from operations for the three and nine months ended November 30, 2011 and November 30, 2010 (dollars in thousands except share and per share amounts):
For the three months ended
For the nine months ended
November 30, 2010
Basic and diluted
6,213
3,310
10,195
12,665
Weighted average common shares outstanding
Earnings per common share-basic and diluted
Note 11. Dividend
On November 15, 2011, we declared a dividend of $3.00 per share payable on December 30, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.0 million or $0.60 per share.
Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 599,584 shares of common stock, or 18% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.117067 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2011. The financial statements for the period ended November 30, 2011 have been retroactively adjusted to reflect the increase in common stock as a result of the dividend in accordance with the provisions of ASC 505-20-S50 regarding disclosure of a capital structure change after the interim balance sheet but before the release of the financial statements.
On November 12, 2010, we declared a dividend of $4.40 per share payable on December 29, 2010. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $1.2 million or $0.44 per share.
Based on shareholder elections, the dividend consisted of approximately $1.2 million in cash and 596,235 shares of common stock, or 22% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 10.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.8049 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2010. The financial statements for the period ended November 30, 2010 have been retroactively adjusted to reflect the increase in common stock as a result of the dividend in accordance with the provisions of ASC 505-20-S50 regarding disclosure of a capital structure change after the interim balance sheet but before the release of the financial statements.
The following tables summarize dividends declared during the nine months ended November 30, 2011 and November 30, 2010 (dollars in thousands except per share amounts):
Amount Per
Date Declared
Record Date
Payment Date
Share *
Total Amount
November 15, 2011
November 25, 2011
December 30, 2011
3.00
9,831
Total dividends declared
November 12, 2010
November 19, 2010
December 29, 2010
4.40
11,796
32
* Amount per share is calculated based on the number of shares outstanding at the date of declaration.
Note 12. Financial Highlights
The following is a schedule of financial highlights for the nine months ended November 30, 2011 and November 30, 2010:
Per share data:(4)
Net asset value at beginning of period
32.75
Net investment income(1)
1.25
Net realized and unrealized gains and losses on investments and derivatives
3.09
5.85
Distributions declared from net investment income
(3.00
(4.40
Other (4)
(2.03
(9.25
Net asset value at end of period
Shares outstanding at end of period
Per share market value at end of period
12.35
17.58
Total return based on market value(2)
(25.80
)%
14.38
Total return based on net asset value(3)
13.80
(4.84
Ratio/Supplemental data:
Ratio of net investment income to average net assets(5)(6)
6.04
2.94
Ratio of operating expenses to average net assets(5)(6)
6.03
14.10
Ratio of incentive management fees to average net assets(6)
1.23
Ratio of credit facility related expenses to average net assets(6)
1.45
4.22
Ratio of total expenses to average net assets(5)(6)
8.71
18.32
(1) Net investment income per share is calculated using the weighted average shares outstanding during the period. For the nine months ended November 30, 2010, excluding the expense waiver and reimbursement arrangement, the net investment income equals $0.70 per share.
(2) Total investment return is calculated assuming a purchase of common shares at the current market value on the first day and a sale at the current market value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s dividend reinvestment plan. Total investment return does not reflect brokerage commissions. Total investment returns covering less than a full period are not annualized.
(3) Total investment return is calculated assuming a purchase of common shares at the current net asset value on the first day and a sale at the current net asset value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s dividend reinvestment plan. Total investment return does not reflect brokerage commissions.
(4) Represents the dilutive effect of issuing common stock below net asset value per share during the period.
(5) For the nine months ended November 30, 2010, net of the expense waiver before the reversal of deferred incentive fee, the ratio of net investment income, operating expenses, total expenses to average net assets is 3.44%, 13.60% and 17.82%, respectively. These ratios for the nine months ended November 30, 2010, net of the expense waiver before the reversal of deferred incentive fee, do not include the effect of the waiver of deferred incentive fees which is (3.83)% on a non-annualized basis as this is a one time waiver.
(6) Ratios are annualized.
33
Note 13. Recapitalization Transaction
In July 2010, we consummated a recapitalization transaction that was necessitated by the fact that we had exceeded permissible borrowing limits under the Revolving Facility in July 2009, which resulted in an event of default under the Revolving Facility. As a result of the event of default under the Revolving Facility, the lender had the right to accelerate repayment of the outstanding indebtedness under the Revolving Facility and to foreclose and liquidate the collateral pledged thereunder. We engaged the investment banking firm of Stifel, Nicolaus & Company to evaluate strategic transaction opportunities and consider alternatives for us in December 2008. On April 14, 2010, we entered into a stock purchase agreement with our Manager and certain of its affiliates and an assignment, assumption and novation agreement with our Manager, pursuant to which we assumed certain rights and obligations of our Manager under a debt commitment letter our Manager received from Madison Capital Funding LLC, indicating Madison Capital Funding’s willingness to provide us with the Replacement Facility, subject to the satisfaction of certain terms and conditions. In addition, we and GSCP (NJ), L.P., our then external investment adviser, entered into a termination and release agreement, to be effective as of the closing of the transaction contemplated by the stock purchase agreement, pursuant to which GSCP (NJ), L.P., among other things, agreed to waive any and all accrued and unpaid deferred incentive management fees up to and as of the closing of the transaction contemplated by the stock purchase agreement but continued to be entitled to receive the base management fees earned through the date of the closing of the transaction contemplated by the stock purchase agreement.
On July 30, 2010, the transactions contemplated by the stock purchase agreement with our Manager and certain of its affiliates was completed, and included the following actions:
· the private sale of shares of our common stock for $15 million in aggregate purchase price to our Manager and certain of its affiliates;
· the closing of the $40 million Replacement Facility with Madison Capital Funding;
· the execution of a registration rights agreement with the investors in the private sale transaction, pursuant to which we agreed to file a registration statement with the SEC to register for resale the shares of our common stock sold in the private sale transaction;
· the execution of a trademark license agreement with our Manager pursuant to which our Manager granted us a non-exclusive, royalty-free license to use the “Saratoga” name, for so long as our Manager or one of its affiliates remains our investment adviser;
· replacing GSCP (NJ), L.P. as our investment adviser and administrator with our Manager by executing an investment advisory and management agreement, which was approved by our stockholders, and an administration agreement with our Manager;
· the resignations of Robert F. Cummings, Jr. and Richard M. Hayden, both of whom are affiliates of GSCP (NJ) L.P., as members of the board of directors and the election of Christian L. Oberbeck and Richard A. Petrocelli, both of whom are affiliates of our Manager, as members of the board of directors;
· the resignation of all of our then existing executive officers and the appointment by our board of directors of Mr. Oberbeck as our chief executive officer and president and Mr. Petrocelli as our chief financial officer, secretary and chief compliance officer; and
· our name change from “GSC Investment Corp.” to “Saratoga Investment Corp.”
We used the net proceeds from the private sale transaction and a portion of the funds available to us under the Replacement Facility to pay the full amount of principal and accrued interest, including default interest, outstanding under Revolving Facility. The Revolving Facility with Deutsche Bank was terminated in connection with our payment of all amounts outstanding thereunder on July 30, 2010.
The Company has reimbursed $630,000 of legal fees to affiliates of our Manager in accordance with the terms of the stock purchase agreement as approved by the board of directors, of which $409,500 has been included in professional fees in the statement of operations, $94,500 have been included in deferred credit facility expenses and are being amortized over the commitment period of the Replacement Facility and $126,000 have been netted against capital in excess of par value.
34
Note 14. Related Party Transactions
On May 31, 2011, we purchased six debt investments with an aggregate face value of $15.6 million and fair value of $10.8 million from Saratoga CLO for $10.8 million. The fair value of the investments was determined by a third party valuation firm. At fair value at May 31, 2011, these investments had an all-in yield of 14.5%, consisting of a current cash yield of 9.2%, a PIK yield of 2.4% and discount yield of 2.9%. We considered the following factors, among others, in connection with our determination to effectuate this purchase transaction:
· These investments are more consistent with our investment objective and strategy, which tends to focus on higher risk, but higher yielding investments, as compared to that of Saratoga CLO;
· We held investments in each of the portfolio companies that issued the six debt investments and, as a result, the transaction represented an opportunity for us to re-deploy idle capital in portfolio companies with which we are very familiar; and
· The transaction permitted Saratoga CLO, of which we hold a 100% equity interest in, to improve its compliance ratios in its investment portfolio.
In November 2011, we and Saratoga CLO sought to purchase a $5.0 million and $3.0 million, respectively, investment in the same portfolio company from an unaffiliated third-party. However, due to certain limitations relating to the investment, we were required to acquire the entire investment and then to subsequently transfer the $3.0 million portion thereof to Saratoga CLO. As a result, on November 30, 2011, we acquired the entire investment from an unaffiliated third-party and transferred the $3.0 million portion thereof to Saratoga CLO on December 1, 2011 in exchange for $3.0 million in cash. The financial account entitled “Other Assets” on the consolidated statement of assets and liabilities includes the $3.0 million portion of this investment that was transferred to Saratoga CLO subsequent to November 30, 2011.
Note 15. Subsequent Events
On December 30, 2011, we paid a dividend of $3.00 per share to shareholders of record as of the close of business on November 25, 2011. Shareholders had until December 22, 2011 to elect whether to receive the dividend in cash (up to an aggregate maximum cash amount of approximately $2.0 million or approximately 20.0% of the total dividend paid) or in shares of common stock. Due to the original terms of the dividend, shareholders who elected to receive cash received a combination of cash and common stock.
Based on shareholder elections, the dividend consisted of $2.0 million in cash and 599,584 shares of common stock, or 18% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.117067 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2011. As previously mentioned in Note 11, the financial statements for the period ended November 30, 2011 have been retroactively adjusted to reflect the increase in common stock as a result of the dividend.
Shareholders who elected to receive the dividend solely in shares of common stock and shareholders who did not make an election received 0.23 shares of common stock for each share of common stock they owned on the record date. Holders of approximately 66.1% of the Company’s common stock elected to receive only stock or did not make an election.
Shareholders electing to receive the dividend in all cash, received cash in the amount of $1.7720718 per share or 59.1% of the $3.00 dividend and 0.09 shares of common stock or 40.9% of the total dividend for each share of common stock they owned on the record date. Cash in lieu of fractional shares was issued.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion should be read in conjunction with our financial statements and related notes and other financial information appearing elsewhere in this quarterly report on Form 10-Q. In addition to historical information, the following discussion and other parts of this quarterly report on Form 10-Q contain forward-looking information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed in Item 1A in our Annual Report on Form 10-K for the fiscal year ended February 28, 2011.
The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us or are within our control. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements.
The forward-looking statements contained in this quarterly report on Form 10-Q involve risks and uncertainties, including statements as to:
· our future operating results;
· our business prospects and the prospects of our portfolio companies;
· the impact of investments that we expect to make;
· our contractual arrangements and relationships with third parties;
· the dependence of our future success on the general economy and its impact on the industries in which we invest;
· the ability of our portfolio companies to achieve their objectives;
· our expected financings and investments, including our ability to obtain a license from the Small Business Administration to operate a Small Business Investment Company subsidiary;
· our regulatory structure and tax treatment, including our ability to operate as a business development company and a regulated investment company;
· the adequacy of our cash resources and working capital;
· the timing of cash flows, if any, from the operations of our portfolio companies; and
· the ability of our investment adviser to locate suitable investments for us and to monitor and effectively administer our investments.
You should not place undue reliance on these forward-looking statements. The forward-looking statements made in this quarterly report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statement to reflect events or circumstances occurring after the date of this quarterly report on Form 10-Q.
OVERVIEW
We are a Maryland corporation that has elected to be treated and regulated as a business development company (“BDC”) under the Investment Company Act of 1940 (the “1940 Act”). Our investment objective is to generate current income and, to a lesser extent, capital appreciation from our investments. We have elected and qualified to be treated as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).
We commenced operations, at the time known as GSC Investment Corp., on March 23, 2007, and completed our initial public offering on March 28, 2007. Prior to July 30, 2010, we were externally managed and advised by GSCP (NJ), L.P., an entity affiliated with GSC Group, Inc. In connection with the consummation of the recapitalization transaction described below on July 30, 2010, we engaged Saratoga Investment Advisors, LLC (“SIA”) to replace GSCP (NJ), L.P. as our investment adviser and changed our name to Saratoga Investment Corp.
Our portfolio is comprised primarily of investments in leveraged loans (both first and second lien term loans) issued by middle market companies. Leveraged loans are generally senior debt instruments that rank ahead of subordinated debt of the portfolio company. Leveraged loans also have the benefit of security interests on the assets of the portfolio company, which may rank ahead of, or be junior to, other security interests. We also purchase mezzanine debt and make equity investments in middle market companies. Mezzanine debt is typically unsecured and subordinated to senior debt of the portfolio company. For purposes of this quarterly report on Form 10-Q, we generally use the term “middle market” to refer to companies with annual EBITDA of between $5 million and $50 million. EBITDA represents earnings before net interest expense, income taxes, depreciation and amortization. Investments in middle market companies are generally less liquid than equivalent investments in companies with larger capitalizations.
While our primary focus is to generate current income and capital appreciation through investments in debt and equity securities of middle market companies, we intend to invest up to 30% of our assets in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt, including securities of companies in bankruptcy, foreign debt, private equity, securities of public companies that are not thinly traded and structured finance vehicles such as collateralized loan obligation funds.
As of November 30, 2011, our portfolio consisted of $85.4 million in investments at fair value, including our investment in the subordinated notes of GSC Investment Corp. CLO 2007 LTD. (“Saratoga CLO”), a collateralized loan obligation fund we manage, which constituted 25.4% of our total assets and, as of November 30, 2011, had a fair value of $25.4 million.
As a BDC, we are required to comply with certain regulatory requirements. For instance, we have to invest at least 70% of our total assets in “qualifying assets,” including securities of U.S. operating companies whose securities are not listed on a national securities exchange, U.S. operating companies with listed securities that have market capitalizations of less than $250 million, cash, cash equivalents, U.S. government securities and high-quality debt investments that mature in one year or less. In addition, we are only allowed to borrow money such that our asset coverage, which, as defined in the 1940 Act, measures the ratio of total assets less total liabilities (excluding borrowings) to total borrowings, equals at least 200% after such borrowing, with certain limited exceptions.
Significant Developments in Our Business
In July 2010, we consummated a recapitalization transaction that was necessitated by the fact that we had exceeded permissible borrowing limits under our revolving securitized credit facility with Deutsche Bank AG, New York Branch in July 2009, which resulted in an event of default under the revolving securitized credit facility. As a result of the event of default under the revolving securitized credit facility, Deutsche Bank had the right to accelerate repayment of the outstanding indebtedness under the revolving securitized credit facility and to foreclose and liquidate the collateral pledged thereunder. We engaged the investment banking firm of Stifel, Nicolaus & Company to evaluate strategic transaction opportunities and consider alternatives for us in December 2008. On April 14, 2010, we entered into a stock purchase agreement with SIA and certain of its affiliates and an assignment, assumption and novation agreement with SIA, pursuant to which we assumed certain rights and obligations of SIA under a debt commitment letter SIA received from Madison Capital Funding LLC, indicating Madison Capital Funding’s willingness to provide us with a $40 million senior secured revolving credit facility, subject to the satisfaction of certain terms and conditions. In addition, we and GSCP (NJ), L.P. entered into a termination and release agreement, to be effective as of the closing of the transaction contemplated by the stock purchase agreement, pursuant to which GSCP (NJ), L.P. among other things, agreed to waive any and all accrued and unpaid deferred incentive management fees up to and as of the closing of the transaction contemplated by the stock
36
purchase agreement but continued to be entitled to receive the base management fees earned through the date of the closing of the transaction contemplated by the stock purchase agreement.
On July 30, 2010, the transactions contemplated by the stock purchase agreement with SIA and certain of its affiliates was completed, and included the following actions:
· the private sale of shares of our common stock for $15 million in aggregate purchase price to SIA and certain of its affiliates;
· the closing of the $40 million senior secured revolving credit facility with Madison Capital Funding;
· the execution of a trademark license agreement with SIA pursuant to which SIA granted us a non-exclusive, royalty-free license to use the “Saratoga” name, for so long as SIA or one of its affiliates remains our investment adviser;
· replacing GSCP (NJ), L.P. as our investment adviser and administrator with SIA by executing an investment advisory and management agreement, which was approved by our stockholders, and an administration agreement with SIA;
· the resignations of Robert F. Cummings, Jr. and Richard M. Hayden, both of whom are affiliates of GSCP (NJ) L.P., as members of the board of directors and the election of Christian L. Oberbeck and Richard A. Petrocelli, both of whom are affiliates of SIA, as members of the board of directors;
· the resignation of all of our then existing executive officers and the appointment by our board of directors of Mr. Oberbeck as our chief executive officer and president and Mr. Petrocelli as our chief financial officer, secretary and chief compliance officer; and,
We used the net proceeds from the private sale transaction and a portion of the funds available to us under the $40 million senior secured revolving credit facility with Madison Capital Funding to pay the full amount of principal and accrued interest, including default interest, outstanding under our revolving securitized credit facility with Deutsche Bank. The revolving securitized credit facility with Deutsche Bank was terminated in connection with our payment of all amounts outstanding thereunder on July 30, 2010.
On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.
Revenues
We generate revenue in the form of interest income and capital gains on the debt investments that we hold and capital gains, if any, on equity interests that we may acquire. We expect our debt investments, whether in the form of first and second lien term loans or mezzanine debt, to have terms of up to ten years, and to bear interest at either a fixed or floating rate. Interest on debt will be payable generally either quarterly or semi-annually. In some cases our debt investments may provide for a portion of the interest to be paid-in-kind (“PIK”). To the extent interest is paid-in-kind, it will be payable through the increase of the principal amount of the obligation by the amount of interest due on the then-outstanding aggregate principal amount of such obligation. The principal amount of the debt and any accrued but unpaid interest will generally become due at the maturity date. In addition, we may generate revenue in the form of commitment, origination, structuring or diligence fees, fees for providing managerial assistance or investment management services and possibly consulting fees. Any such fees will be generated in connection with our investments and recognized as earned. We may also invest in preferred equity securities that pay dividends on a current basis.
On January 22, 2008, we entered into a collateral management agreement with Saratoga CLO pursuant to which we act as its collateral manager and receive a senior collateral management fee of 0.10% and a subordinate collateral management fee of 0.40% of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds. We are also entitled to an incentive management fee equal to 20% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return equal to or greater than 12%.
We recognize interest income on our investment in the subordinated notes of Saratoga CLO using the effective interest method, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.
37
Expenses
Our primary operating expenses include the payment of investment advisory and management and incentive fees, professional fees, directors’ and officers’ insurance, fees paid to independent directors and administrator expenses, including our allocable portion of our administrator’s overhead. Our allocable portion is based on the ratio of our total assets to the total assets administered by our administrator. Our investment management fees compensate our investment adviser for its work in identifying, evaluating, negotiating, closing and monitoring our investments. We bear all other costs and expenses of our operations and transactions, including those relating to:
· our organization;
· calculating our net asset value (including the cost and expenses of any independent valuation firm);
· expenses incurred by our investment adviser payable to third parties, including agents, consultants or other advisers, in monitoring our financial and legal affairs and in monitoring our investments and performing due diligence on our prospective portfolio companies;
· interest payable on debt, if any, incurred to finance our investments;
· offerings of our common stock and other securities;
· investment advisory and management fees;
· fees payable to third parties, including agents, consultants or other advisers, relating to, or associated with, evaluating and making investments;
· transfer agent and custodial fees;
· federal and state registration fees;
· all costs of registration and listing our common stock on any securities exchange;
· federal, state and local taxes;
· independent directors’ fees and expenses;
· costs of preparing and filing reports or other documents required by governmental bodies (including the SEC);
· costs of any proxy statements or other notices to stockholders, including printing costs;
· our fidelity bond, directors and officers/errors and omissions liability insurance, and any other insurance premiums;
· direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs; and
· administration fees and all other expenses incurred by us or, if applicable, the administrator in connection with administering our business (including payments under the administration agreement based upon our allocable portion of the administrator’s overhead in performing its obligations under the administration agreement, including rent and the allocable portion of the cost of our officers and their respective staffs (including travel expenses)).
The amount payable to GSCP (NJ), L.P., our former investment adviser and administrator, as administrator was capped to the effect that such amount, together with our other operating expenses, could not exceed an amount equal to 1.5% per annum of our net assets attributable to common stock. In addition, for the one-year term of the administration agreement expiring on March 21, 2011, GSCP (NJ), L.P. had agreed to waive our reimbursement obligation under the administration agreement until our total assets exceeded $500 million. The amount payable to SIA as administrator is capped at $1.0 million for the initial two years of the term of the administration agreement.
Pursuant to the investment advisory and management agreement that we had with GSCP (NJ), L.P., our former investment adviser and administrator, we had agreed to pay GSCP (NJ), L.P. as investment adviser a quarterly base management fee of 1.75% of the average value of our total assets (other than cash or cash equivalents but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters, and appropriately adjusted for any share issuances or repurchases during the applicable fiscal quarter, and an incentive fee.
The incentive fee had two parts:
· A fee, payable quarterly in arrears, equal to 20% of our pre-incentive fee net investment income, expressed as a rate of return on the value of the net assets at the end of the immediately preceding quarter, that exceeded a 1.875% quarterly (7.5% annualized) hurdle rate measured as of the end of each fiscal quarter. Under this provision, in any fiscal quarter, our investment adviser received no incentive fee unless our pre-incentive fee net investment income exceeded the hurdle rate of 1.875%. Amounts received as a return of capital were not included in calculating this portion of the incentive fee. Since the hurdle rate was based on net assets, a return of less than the hurdle rate on total assets could still have resulted in an incentive fee.
38
· A fee, payable at the end of each fiscal year, equal to 20% of our net realized capital gains, if any, computed net of all realized capital losses and unrealized capital depreciation, in each case on a cumulative basis, less the aggregate amount of capital gains incentive fees paid to the investment adviser through such date.
We deferred cash payment of any incentive fee otherwise earned by our former investment adviser if, during the then most recent four full fiscal quarter period ending on or prior to the date such payment was to be made, the sum of (a) our aggregate distributions to our stockholders and (b) our change in net assets (defined as total assets less liabilities before taking into account any incentive fees payable during that period) was less than 7.5% of our net assets at the beginning of such period. These calculations were appropriately pro rated for the first three fiscal quarters of operation and adjusted for any share issuances or repurchases during the applicable period. Such incentive fee would become payable on the next date on which such test had been satisfied for the most recent four full fiscal quarters or upon certain terminations of the investment advisory and management agreement. We commenced deferring cash payment of incentive fees during the quarterly period ended August 31, 2007, and continued to defer such payments through the quarterly period ended May 31, 2010. As of July 30, 2010, the date on which GSCP (NJ), L.P. ceased to be our investment adviser and administrator, we owed GSCP (NJ), L.P. $2.9 million in fees for services previously provided to us. GSCP (NJ), L.P. agreed to waive payment by us of the remaining $2.6 million in connection with the consummation of the stock purchase transaction with SIA and certain of its affiliates described above.
The terms of the investment advisory and management agreement with SIA, our current investment adviser, is substantially similar to the terms (i.e., a quarterly base management fee of 1.75% of the average value of our total assets —other than cash or cash equivalents but including assets purchased with borrowed funds—at the end of the two most recently completed fiscal quarters, and an incentive fee) of the investment advisory and management agreement we had entered into with GSCP (NJ), L.P., our former investment adviser, except for the following material distinctions in the fee terms:
· The capital gains portion of the incentive fee was reset with respect to gains and losses from May 31, 2010, and therefore losses and gains incurred prior to such time will not be taken into account when calculating the capital gains fee payable to SIA and, as a result, SIA will be entitled to 20% of realized gains net of unrealized losses and realized losses that arise after May 31, 2010. In addition, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 equal the fair value of such investment as of such date. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P., the capital gains fee was calculated from March 21, 2007, and the gains were substantially outweighed by losses.
· Under the “catch up” provision, 100% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income that exceeds 1.875% (7.5% annualized) but is less than or equal to 2.344% in any fiscal quarter is payable to SIA. This will enable SIA to receive 20% of all net investment income as such amount approaches 2.344% in any quarter, and SIA will receive 20% of any additional net investment income. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P. only received 20% of the excess net investment income over 1.875%.
To the extent that any of our leveraged loans are denominated in a currency other than U.S. dollars, we may enter into currency hedging contracts to reduce our exposure to fluctuations in currency exchange rates. We may also enter into interest rate hedging agreements. Such hedging activities, which will be subject to compliance with applicable legal requirements, may include the use of interest rate caps, futures, options and forward contracts. Costs incurred in entering into or settling such contracts will be borne by us.
PORTFOLIO AND INVESTMENT ACTIVITY
Corporate Debt Portfolio Overview(1)
At November 30, 2011
At February 28, 2011
($ in millions)
Number of investments
Number of portfolio companies
Average investment size
1.9
Weighted average maturity
3.0 years
3.1 years
Number of industries
Average investment per portfolio company
Non-Performing or delinquent investments
Fixed rate debt (% of interest bearing portfolio)
9.4 (17.3
9.4 (18.6
Weighted average current coupon
13.9
13.8
Floating rate debt (% of interest bearing portfolio)
44.6 (82.7
41.1 (81.4
Weighted average current spread over LIBOR
5.6
39
(1) Excludes our investment in the subordinated notes of Saratoga CLO and limited partnership interests which, as of November 30, 2011, constituted 25.4% of our total assets.
During the three months ended November 30, 2011, we made $11.4 million of investments in new or existing portfolio companies, had $18.4 million in aggregate amount of exits and repayments, resulting in net repayments of $7.0 million for the period. During the three months ended November 30, 2010, we made $1.6 million of investments in new or existing portfolio companies, had $6.7 million in aggregate amount of exits and repayments, resulting in net repayments of $5.1 million for the period.
During the nine months ended November 30, 2011, we made $28.9 million of investments in new or existing portfolio companies, had $31.9 million in aggregate amount of exits and repayments, resulting in net repayments of $3.0 million for the period. During the nine months ended November 30, 2010, we made $1.6 million investments in new or existing portfolio companies and had $9.5 million in aggregate amount of exits and repayments, resulting in net repayments of $7.9 million for the period.
Our portfolio composition based on fair value at November 30, 2011 and February 28, 2011 was as follows:
Portfolio Composition
Percentage of Total Portfolio
Weighted Average Current Yield
10.7
9.5
Saratoga CLO subordinated notes
22.7
15.8
18.3
15.9
Equity interests
N/A
19.1
Limited partnership interests
14.4
11.5
Our investment in the subordinated notes of Saratoga CLO represents a first loss position in a portfolio that, at November 30, 2011 and February 28, 2011, was composed of $389.5 million and $410.2 million, respectively, in aggregate principal amount of predominantly senior secured first lien term loans. This investment is subject to unique risks. Please see Part II, Item 1A “Risk Factors—Our investment in GSC Investment Corp. CLO 2007 LTD, constitutes a leveraged investment in a portfolio of predominantly senior secured first lien term loans and is subject to additional risks and volatility” in our annual report on Form 10-K for the year ended February 28, 2011 and “Note 4. Investment in GSC Investment Corp. CLO 2007 Ltd.” in this quarterly report on Form 10-Q for more information about Saratoga CLO. We do not consolidate the Saratoga CLO portfolio in our financial statements. Accordingly, the metrics below do not include the underlying Saratoga CLO portfolio investments. However, at November 30, 2011, over 98% of the Saratoga CLO portfolio investments had a CMR (as defined below) color rating of green or yellow and one Saratoga CLO portfolio investment was in default. At February 28, 2011, 97.0% of the Saratoga CLO portfolio investments had a CMR color rating of green or yellow and three Saratoga CLO portfolio investments were in default.
SIA normally grades all of our investments using a credit and monitoring rating system (“CMR”). The CMR consists of a single component: a color rating. The color rating is based on several criteria, including financial and operating strength, probability of default, and restructuring risk. The color ratings are characterized as follows: (Green) - strong credit; (Yellow) - satisfactory credit; (Red) - payment default risk, in payment default and/or significant restructuring activity.
40
The CMR distribution of our investments at November 30, 2011 and February 28, 2011 was as follows:
Portfolio CMR Distribution
($ in thousands)
N/A(1)
31,372
36.7
29,467
36.8
Green
31,333
10,900
13.6
Yellow
16,944
19.9
14,998
18.8
Red
5,730
6.7
24,660
30.8
(1) Comprised of our investments in the subordinated notes of Saratoga CLO, equity interests, and limited partnership interests.
The following table shows the portfolio composition by industry grouping at fair value at November 30, 2011 and February 28, 2011.
Portfolio composition by industry grouping at fair value
Structured Finance Securities (1)
11,185
13.1
2,499
8,765
8,634
10.8
7,749
9.1
10,249
12.8
6,671
7.8
4,231
5.3
5,490
6.4
245
4,814
8,014
10.0
4,724
5.5
5,855
3,500
2,353
2,952
1,652
1,710
1,436
1,546
735
816
717
259
213
155
7,358
9.2
2,453
Oil & Gas
317
(1) Comprised of our investment in the subordinated notes of Saratoga CLO.
The following table shows the portfolio composition by geographic location at fair value at November 30, 2011 and February 28, 2011. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.
41
Portfolio composition by geographic location at fair value
($ in thousands )
Other(1)
West
22,376
26.2
16,332
20.4
Southeast
16,176
19.0
7,815
9.8
Midwest
15,435
18.1
18,490
Northeast
6,017
12,203
15.2
International
RESULTS OF OPERATIONS
Operating results for the three and nine months ended November 30, 2011 and 2010 are as follows;
3,629
5,092
Total expenses, net
2,805
3,157
824
1,935
Net realized losses
(5,832
(13,731
Net unrealized gains
11,221
15,106
Net increase in net assets resulting from operations
10,065
11,015
5,942
6,596
4,123
4,419
(16,280
11,912
24,526
Investment income
The composition of our investment income for the three and nine months ended November 30, 2011 and 2010 was as follows:
Investment Income
3,033
4,581
Management fee income from Saratoga CLO
502
509
Interest from cash and cash equivalents and other income
94
8,307
9,417
1,512
1,523
246
75
42
For the three months ended November 30, 2011, total investment income decreased $1.5 million, or 28.7%, compared to the three months ended November 30, 2010. The decrease in total investment income for the three months ended November 30, 2011 versus the three months ended November 30, 2010 was the result of a one-time reversal of previously reserved accrued interest on one investment that was taken off of non-accrual status during the three months ended November 30, 2010 partially, offset by higher interest income recognized on our investment in Saratoga CLO during the three months ended November 30, 2011.
For the nine months ended November 30, 2011, total investment income decreased $1.0 million, or 8.6%, compared to the nine months ended November 30, 2010. The decrease in total investment income for the nine months ended November 30, 2011 versus the nine months ended November 30, 2010 was the result of a one-time reversal of previously reserved accrued interest on one investment that was taken off of non-accrual status during the nine months ended November 30, 2010 partially, offset by higher interest income recognized on our other investments during the nine months ended November 30, 2011.
For the three and nine months ended November 30, 2011, total PIK income was $0.3 million and $1.2 million, respectively. For the three and nine months ended November 30, 2010, total PIK income was $0.3 million and $0.9 million, respectively.
Operating Expenses
The composition of our operating expenses for the three and nine months ended November 30, 2011 and 2010 was as follows:
Interest and credit facility expense
307
619
394
424
356
381
1,179
1,173
250
240
Insurance expenses
145
171
Directors fees
48
General and administrative and other expenses
123
101
Total operating expenses before manager waiver and reimbursement
987
2,188
1,204
1,259
1,282
3,138
842
730
569
449
537
153
321
295
306
9,491
For the three months ended November 30, 2011, total operating expenses before manager expense waiver and reimbursement decreased $0.4 million, or 11.1%, compared to the three months ended November 30, 2010. For the nine months ended November 30, 2011, total operating expenses before manager expense waiver and reimbursement decreased $3.5 million, or 37.4%, compared to the nine months ended November 30, 2010. These decreases were primarily attributable to a decrease in professional fees related to the recapitalization transaction described in “Note 13. Recapitalization Transaction”, a decrease in interest and credit facility expense attributable to a decrease in the amount of our outstanding debt and a decrease of incentive management fees relating to unrealized appreciation in our investments.
As discussed above, the decrease in interest and credit facility expense for the three and nine months ended November 30, 2011 is primarily attributable to a decrease in the amount of outstanding debt, during such periods. In this regard, there were outstanding balances under our senior secured revolving credit facility with Madison Capital of $4.5 million at February 28, 2011 and no outstanding balance at November 30, 2011. In the prior period, we had outstanding balances under our revolving securitized credit
43
facility with Deutsche Bank of $37.0 million at February 28, 2010 and $33.8 million at May 31, 2010, which were repaid on July 30, 2010 in connection with the recapitalization transaction, including through the use of $20 million of borrowings under the senior secured revolving credit facility with Madison Capital Funding. For three months ended November 30, 2011, there was no outstanding indebtedness. For the three months ended November 30, 2010, the weighted average interest rate on our outstanding indebtedness was 7.5%. For the nine months ended November 30, 2011 and November 30, 2010, the weighted average interest rate on our outstanding indebtedness was 7.50% and 8.72%, respectively.
Net Realized Gains/Losses from Investments
For the three months ended November 30, 2011, we had $18.4 million of sales, repayments, exits and restructurings, resulting in $5.8 million of net realized losses. The most significant realized gains and losses during the three months ended November 30, 2011 were as follows:
Three months ended November 30, 2011
Issuer
Asset Type
Gross Proceeds
Net Realized Gain/(Loss)
Energy Alloys, LLC
Grant U.S. Holdings LLP
6,348
(6,348
Specialized Technology Resources
5,000
4,852
148
For the nine months ended November 30, 2011, we had $31.9 million of sales, repayments, exits and restructurings resulting in $5.8 million of net realized losses. The most significant realized gains and losses during the nine months ended November 30, 2011 were as follows:
Nine months ended November 30, 2011
First Lien Term Loan
3,205
3,109
96
For the three months ended November 30, 2010, we had $20.4 million of sales, repayments, exits and restructurings, resulting in $13.7 million of net realized losses.
Three months ended November 30, 2010
Bankruptcy Management Solution, Inc.
2,406
4,793
(2,387
Jason Incorporated
2,354
13,700
(11,346
For the nine months ended November 30, 2010, we had $23.2 million of sales, repayments, exits or restructurings resulting in $16.3 million of net realized losses.
Nine months ended November 30, 2010
Custom Direct, Inc.
1,832
1,535
297
Legacy Cabinets, Inc.
139
2,002
(1,863
1,496
(994
44
Net Unrealized Appreciation/Depreciation on Investments
For the three months ended November 30, 2011, our investments had a decrease in net unrealized depreciation of $11.2 million versus a decrease in net unrealized depreciation of $15.1 million for the three months ended November 30, 2010. For the nine months ended November 30, 2011, our investments had a decrease in net unrealized depreciation of $11.9 million versus a decrease in net unrealized depreciation of $24.5 million for the nine months ended November 30, 2010. The most significant cumulative changes in unrealized appreciation and depreciation for the nine months ended November 30, 2011 were the following:
Total Unrealized
Year-To-Date Change in Unrealized
Appreciation/(Depreciation)
Pracs Institute, LTD.
4,078
(4,078
(3,023
Penton Media
4,229
2,947
(1,282
(1,192
Saratoga CLO
1,012
The increase in unrealized depreciation in our investments in Pracs Institute, LTD. and Penton Media were due to declining prospects for the companies. The $5.6 million net unrealized appreciation in our investment in the Saratoga CLO subordinated notes was due to higher cash flow projections (based on an improvement in the overall portfolio, a decrease in the assumed portfolio default rate and an improvement in reinvestment assumptions based on current market conditions and projections) and a lower discount rate used to present value the cash flows based on current market conditions.
For the three months ended November 30, 2010, our investments had a decrease in net unrealized depreciation of $15.1 million. For the nine months ended November 30, 2010, our investments had a decrease in net unrealized depreciation of $24.5 million. The most significant cumulative changes in unrealized appreciation and depreciation for the nine months ended November 30, 2010, were the following:
28,415
23,038
(5,377
7,158
567
2,852
2,285
2,614
The $7.2 million net unrealized appreciation in our investment in the Saratoga CLO subordinated notes was due to higher cash flow projections based on an increase in principal balance and an improvement in the overcollateralization ratios, a decrease in the assumed portfolio default rate (based on better than forecast actual default rates and improved default forecasts), and an improvement in reinvestment assumptions based on current market conditions and projections. In addition, for the nine months ended November 30, 2010, we had approximately $24.5 million of unrealized gains due to the reversal of previously recorded unrealized losses in connection with the restructurings of certain investments, including approximately $12.0 million relating to Jason Incorporated, $2.8 million related to Legacy Cabinets, Inc. and $0.6 million related to Terphane Holdings, Inc.
Net Unrealized Appreciation/Depreciation on Derivatives
For the three months ended November 30, 2011, changes in the value of our interest rate caps resulted in unrealized appreciation of $166 versus an unrealized depreciation of $1,366 for the three months ended November 30, 2010. For the nine months ended November 30, 2011, changes in the value of our interest rate caps resulted in unrealized depreciation of $15,108 versus an unrealized depreciation of $19,797 for the nine months ended November 30, 2010. For a more detailed discussion of the interest rate caps, see “Note 7. Interest Rate Cap Agreements” to our consolidated financial statements included elsewhere in this quarterly report on Form 10-Q.
Changes in Net Assets from Operations
For the three months ended November 30, 2011, we recorded a net increase in net assets resulting from operations of $6.2 million versus a net increase in net assets resulting from operations of $3.3 million for the three months ended November 30, 2010. The difference is attributable to an decrease in net realized loss from investments, partially offset by a decrease in net investment income and a
45
decrease in net unrealized appreciation on investments for the three months ended November 30, 2011, as compared to the same period in the prior year. Based on 3,310,021 and 2,752,914 weighted average common shares outstanding for the three months ended November 30, 2011 and November 30, 2010, respectively, our per share net increase in net assets resulting from operations was $1.88 for the three months ended November 30, 2011 versus a per share net increase in net assets from operations of $1.20 for the three months ended November 30, 2010.
For the nine months ended November 30, 2011, we recorded a net increase in net assets resulting from operations of $10.2 million versus a net increase in net assets resulting from operations of $12.7 million for the nine months ended November 30, 2010. The difference is attributable to a decrease in net unrealized appreciation on investments, partially offset by a decrease in net realized loss from investments for the nine months ended November 30, 2011, as compared to the same period in the prior year. Based on 3,287,979 and 2,162,832 weighted average common shares outstanding for the nine months ended November 30, 2011 and November 30, 2010, respectively, our per share net increase in net assets resulting from operations was $3.10 for the nine months ended November 30, 2011 versus a per share net increase in net assets from operations of $5.86 for the nine months ended November 30, 2010.
46
FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES
On April 11, 2007, we entered into a $100.0 million revolving securitized credit facility (the “Revolving Facility”). On May 1, 2007, we entered into a $25.7 million term securitized credit facility (the “Term Facility” and, together with the Revolving Facility, the “Facilities”), which was fully drawn at closing. In December 2007, we consolidated the Facilities by using a draw under the Revolving Facility to repay the Term Facility. In response to the market wide decline in financial asset prices, which negatively affected the value of our portfolio, we terminated the revolving period of the Revolving Facility effective January 14, 2009 and commenced a two-year amortization period during which all principal proceeds from the collateral was used to repay outstanding borrowings. In March 2009, we amended the Revolving Facility to decrease the minimum required collateralization and increase the portion of the portfolio that can be invested in “CCC” rated investments in return for an increased interest rate and expedited amortization.
On July 30, 2009, an event of default under the Revolving Facility occurred. As a result of this event of default, the lender under the Revolving Facility had the right to accelerate repayment of the outstanding indebtedness and to foreclose and liquidate the collateral pledged thereunder. Due to the event of default, the interest rate on the Revolving Facility increased from the commercial paper rate plus 4.00% to an interest rate at February 28, 2010 and May 31, 2010 of 9.25%.
At November 30, 2011 and February 28, 2011, we had $0.0 million and $4.5 million, respectively, in borrowings under the Revolving Facility versus $37.0 million in borrowings at February 28, 2010.
On July 30, 2010, we used the net proceeds from the stock purchase transaction with SIA and certain of its affiliates and a portion of the funds available to us under the senior secured revolving credit facility with Madison Capital Funding to pay the full amount of principal and accrued interest, including default interest, outstanding under the Revolving Facility. Below is a summary of the terms of the $40 million senior secured revolving credit facility we have with Madison Capital Funding (the “Replacement Facility”).
Availability. Under the Replacement Facility, we can draw up to the lesser of (i) $40 million (the “Facility Amount”) and (ii) the product of the applicable advance rate (which varies from 50% to 75% depending on the type of loan asset) and the value, determined in accordance with the Replacement Facility (the “Adjusted Borrowing Value”), of certain “eligible” loan assets pledged as security for the loan (the “Borrowing Base”), in each case less (a) the amount of any undrawn funding commitments we have under any loan asset and which are not covered by amounts in the Unfunded Exposure Account referred to below (the “Unfunded Exposure Amount”) and (b) outstanding borrowings. Each loan asset held by us as of the date on which the Replacement Facility was closed was valued as of that date and each loan asset that we acquire after such date will be valued at the lowest of its fair value, its face value (excluding accrued interest) and the purchase price paid for such loan asset. Adjustments to the value of a loan asset will be made to reflect, among other things, changes in its fair value, a default by the obligor on the loan asset, insolvency of the obligor, acceleration of the loan asset, and certain modifications to the terms of the loan asset.
The Replacement Facility contains limitations on the type of loan assets that are “eligible” to be included in the Borrowing Base and as to the concentration level of certain categories of loan assets in the Borrowing Base such as restrictions on geographic and industry concentrations, asset size and quality, payment frequency, status and terms, average life, and collateral interests. In addition, if an asset is to remain an “eligible” loan asset, we may not make changes to the payment, amortization, collateral and certain other terms of the loan assets without the consent of the administrative agent that will either result in subordination of the loan asset or be materially adverse to the lenders.
At any time prior to the second anniversary of the closing of the Replacement Facility and subject to certain conditions, we may request an increase in the Facility Amount of up to $60 million for a combined aggregate Facility Amount of $100 million.
Collateral. The Replacement Facility is secured by substantially all of our assets and includes the subordinated notes (“CLO Notes”) issued by Saratoga CLO and our rights under the CLO Management Agreement (as defined below).
Interest Rate and Fees. Under the Replacement Facility, funds are borrowed at the greater of the prevailing LIBOR rate and 2.00%, plus an applicable margin of 5.50%. At our option, funds may be borrowed based on an alternative base rate, which in no event will be less than 3.00%, and the applicable margin over such alternative base rate is 4.50%. In addition, we will pay the lenders a commitment fee of 0.75% per year on the unused amount of the Replacement Facility for the duration of the Revolving Period (defined below). Accrued interest and commitment fees are payable monthly. We were also obligated to pay certain other fees to the lenders in connection with the closing of the Replacement Facility.
47
Revolving Period and Maturity Date. We may make and repay borrowings under the Replacement Facility for a period of three years following the closing of the Replacement Facility (the “Revolving Period”). The Revolving Period may be terminated at an earlier time by us or, upon the occurrence of an event of default, by action of the lenders or automatically. All borrowings and other amounts payable under the Replacement Facility are due and payable in five years after the end of the Revolving Period.
Collateral Tests. It is a condition precedent to any borrowing under the Replacement Facility that the principal amount outstanding under the Replacement Facility, after giving effect to the proposed borrowings, not exceed the lesser of the Borrowing Base or the Facility Amount (the “Borrowing Base Test”). In addition to satisfying the Borrowing Base Test, the following tests must also be satisfied (together with Borrowing Base Test, the “Collateral Tests”):
· Interest Coverage Ratio. The ratio (expressed as a percentage) of interest collections with respect to pledged loan assets, less certain fees and expenses relating to the Replacement Facility, to accrued interest and commitment fees and any breakage costs payable to the lenders under the Replacement Facility for the last 6 payment periods must equal at least 175%.
· Overcollateralization Ratio. The ratio (expressed as a percentage) of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets plus the fair value of certain ineligible pledged loan assets and the CLO Notes (in each case, subject to certain adjustments) to outstanding borrowings under the Replacement Facility plus the Unfunded Exposure Amount must equal at least 200%.
· Weighted Average FMV Test. The aggregate adjusted or weighted value of “eligible” pledged loan assets as a percentage of the aggregate outstanding principal balance of “eligible” pledged loan assets must be equal to or greater than 72% and 80% during the one-year periods prior to the first and second anniversary of the closing date, respectively, and 85% at all times thereafter.
The Replacement Facility also requires payment of outstanding borrowings or replacement of pledged loan assets upon our breach of our representation and warranty that pledged loan assets included in the Borrowing Base are “eligible” loan assets. Such payments or replacements must equal the lower of the amount by which the Borrowing Base is overstated as a result of such breach or any deficiency under the Collateral Tests at the time of repayment or replacement. Compliance with the Collateral Tests is also a condition to the discretionary sale of pledged loan assets by us.
Priority of Payments. During the Revolving Period, the priority of payments provisions of the Replacement Facility require, after payment of specified fees and expenses and any necessary funding of the Unfunded Exposure Account, that collections of principal from the loan assets and, to the extent that these are insufficient, collections of interest from the loan assets, be applied on each payment date to payment of outstanding borrowings if the Borrowing Base Test, the Overcollateralization Ratio and the Interest Coverage Ratio would not otherwise be met. Similarly, following termination of the Revolving Period, collections of interest are required to be applied, after payment of certain fees and expenses, to cure any deficiencies in the Borrowing Base Test, the Interest Coverage Ratio and the Overcollateralization Ratio as of the relevant payment date.
Reserve Account. The Replacement Facility requires us to set aside an amount equal to the sum of accrued interest, commitment fees and administrative agent fees due and payable on the next succeeding three payment dates (or corresponding to three payment periods). If for any monthly period during which fees and other payments accrue, the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets which do not pay cash interest at least quarterly exceeds 15% of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets, we are required to set aside such interest and fees due and payable on the next succeeding six payment dates. Amounts in the reserve account can be applied solely to the payment of administrative agent fees, commitment fees, accrued and unpaid interest and any breakage costs payable to the lenders.
Unfunded Exposure Account. With respect to revolver or delayed draw loan assets, we are required to set aside in a designated account (the “Unfunded Exposure Account”) 100% of our outstanding and undrawn funding commitments with respect to such loan assets. The Unfunded Exposure Account is funded at the time we acquire a revolver or delayed draw loan asset and request a related borrowing under the Replacement Facility. The Unfunded Exposure Account is funded through a combination of proceeds of the requested borrowing and our other funds, and if for any reason such amounts are insufficient, through application of the priority of payment provisions described above.
Operating Expenses. The priority of payments provision of the Replacement Facility provides for the payment of certain of our operating expenses out of collections on principal and interest during the Revolving Period and out of collections on interest following the termination of the Revolving Period in accordance with the priority established in such provision. The operating expenses payable pursuant to the priority of payment provisions is limited to $350,000 for each monthly payment date or $2.5 million for the immediately preceding period of twelve consecutive monthly payment dates. This ceiling can be increased by the lesser of 5% or the percentage increase in the fair market value of all of our assets only on the first monthly payment date to occur after each one-
year anniversary following the closing of the Replacement Facility. Upon the occurrence of a Manager Event (described below), the consent of the administrative agent is required in order to pay operating expenses through the priority of payments provision.
Events of Default. The Replacement Facility contains certain negative covenants, customary representations and warranties and affirmative covenants and events of default. The Replacement Facility does not contain grace periods for breach by us of certain covenants, including, without limitation, preservation of existence, negative pledge, change of name or jurisdiction and our separate legal entity status covenants and certain other customary covenants. Other events of default under the Replacement Facility include, among other things, the following:
· an Interest Coverage Ratio of less than 175%;
· an Overcollateralization Ratio of less than 200%;
· the filing of certain ERISA or tax liens; and
· the occurrence of certain “Manager Events” such as:
· failure by SIA and its affiliates to maintain collectively, directly or indirectly, a cash equity investment in us in an amount equal to at least $5,000,000 at any time prior to the third anniversary of the closing date of the Replacement Facility;
· failure of the management agreement between SIA and us to be in full force and effect;
· indictment or conviction of SIA or any “key person” for a felony offense, or any fraud, embezzlement or misappropriation of funds by SIA or any “key person” and, in the case of “key persons,” without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed to replace such key person within 30 days;
· resignation, termination, disability or death of a “key person” or failure of any “key person” to provide active participation in SIA’s daily activities, all without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed within 30 days; or,
· occurrence of any event constituting “cause” under the Collateral Management Agreement between the Company and Saratoga CLO (the “CLO Management Agreement”), delivery of a notice under Section 12(c) of the CLO Management Agreement with respect to the removal of the Company as collateral manager or we cease to act as collateral manager under the CLO Management Agreement.
Conditions to Acquisitions and Pledges of Loan Assets. The Replacement Facility imposes certain additional conditions to the acquisition and pledge of additional loan assets. Among other things, we may not acquire additional loan assets without the prior written consent of the administrative agent until such time that the administrative agent indicates in writing its satisfaction with SIA’s policies, personnel and processes relating to the loan assets.
Fees and Expenses. We paid certain fees and reimbursed Madison Capital Funding for the aggregate amount of all documented, out-of-pocket costs and expenses, including the reasonable fees and expenses of lawyers, incurred by Madison Capital Funding in connection with the Replacement Facility and the carrying out of any and all acts contemplated thereunder up to and as of the date of closing of the stock purchase transaction with SIA and certain of its affiliates. These amounts totaled $2.0 million.
As of November 30, 2011, we had no outstanding borrowings under the Replacement Facility and were in compliance with the asset coverage test under the 1940 Act.
Our asset coverage ratio, as defined in the 1940 Act, was 2,013% as of February 28, 2011.
At November 30, 2011 and February 28, 2011, the fair value of investments, cash and cash equivalents and cash and cash equivalents, securitization accounts were as follows:
Percent of Total
7,942
10,736
11.3
834
4,370
4.6
35,829
38.0
19.4
8,817
9.4
21.3
7,406
10.4
2.1
23.9
Common stock
5,996
Other/limited partnership interests
94,155
95,131
49
On November 15, 2011, our board of directors declared a dividend of $3.00 per share payable on December 30, 2011, to common stockholders of record on November 25, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.0 million or $0.60 per share.
Based on shareholder elections, the dividend consisted of $2.0 million in cash and 599,584 shares of common stock, or 18% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.117067 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2011.
On November 12, 2010, our board of directors declared a dividend of $4.40 per share payable on December 29, 2010, to common stockholders of record on November 19, 2010. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $1.2 million or $0.44 per share.
Based on shareholder elections, the dividend consisted of $1.2 million in cash and 596,265 shares of common stock, or 22% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 10.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.8049 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2010.
On November 13, 2009, our board of directors declared a dividend of $18.25 per share payable on December 31, 2009, to common stockholders of record on November 25, 2009. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.1 million or $0.25 per share.
Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872.5 shares of common stock, or 104% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 13.7% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.099 per share, which equaled the volume weighted average trading price per share of the common stock on December 24 and 28, 2009.
On December 8, 2008, our board of directors declared a cash dividend of $2.50 per share payable on December 29, 2008, to common stockholders of record on December 18, 2008.
We intend to continue to generate cash primarily from cash flows from operations, including interest earned from the temporary investment of cash in U.S. government securities and other high-quality debt investments that mature in one year or less, future borrowings and future offerings of securities.
Although we expect to fund the growth of our investment portfolio through the net proceeds from future equity offerings, including our dividend reinvestment plan, and issuances of senior securities or future borrowings, to the extent permitted by the 1940 Act, we cannot assure you that our plans to raise capital will be successful. In this regard, because our common stock has historically traded at a price below our current net asset value per share and we are limited in our ability to sell our common stock at a price below net asset value per share, we have been and may continue to be limited in our ability to raise equity capital. Our stockholders approved a proposal at our annual meeting of stockholders held on September 27, 2011 that authorizes us to sell shares of our common stock below the then current net asset value per share in one or more offerings for a period ending on the earlier of September 27, 2012 or the date of our next annual meeting of stockholders. Our board of directors adopted a policy that requires us to sell or issue shares of our common stock at an offering price per share that is not less than 85% of the then current net asset value per share pursuant to this proposal. No change can be made to this policy without unanimous approval of our independent directors. We would need stockholder approval of a similar proposal to issue shares below net asset value per share at any time after our next annual meeting of stockholders.
50
In addition, we intend to distribute to our stockholders substantially all of our taxable income in order to satisfy the requirements applicable to RICs under Subchapter M of the Code. Consequently, we may not have the funds or the ability to fund new investments, to make additional investments in our portfolio companies, to fund our unfunded commitments to portfolio companies or to repay borrowings. Also, the illiquidity of our portfolio investments may make it difficult for us to sell these investments when desired and, if we are required to sell these investments, we may realize significantly less than their recorded value.
As a BDC, we generally are required to meet a coverage ratio of total assets, less liabilities and indebtedness not represented by senior securities, to total senior securities, which include all of our borrowings and any outstanding preferred stock, of at least 200%. This requirement limits the amount that we may borrow.
Finally, we are considering other measures to help ensure adequate liquidity, including the formation and operation of a Small Business Investment Company (“SBIC”) subsidiary.
On September 14, 2011, the Small Business Administration (“SBA”) issued us a “green light” or “go forth” letter inviting us to continue our application process to obtain a license to form and operate an SBIC subsidiary. We began the application process earlier this year and recently met with the investment committee of the Investment Division of the SBA, which voted to permit us to advance to the second part of the process. The receipt of the SBIC application is subject to the approval of the SBA. We remain cautiously optimistic that we will successfully complete the application process. However, we have received no assurance or indication from the SBA that we will receive a license, or of the timeframe in which we would receive a license, should one ultimately be granted.
Our SBIC subsidiary will be a wholly-owned subsidiary, have an investment objective similar to ours and make similar types of investments in accordance with SBIC regulations.
To the extent that we receive an SBIC license, our SBIC subsidiary will be allowed to issue SBA-guaranteed debentures, subject to the required capitalization of the SBIC subsidiary. SBA guaranteed debentures carry long-term fixed rates that are generally lower than rates on comparable bank and other debt. Under the regulations applicable to SBICs, an SBIC may have outstanding debentures guaranteed by the SBA generally in an amount up to twice its regulatory capital, which generally equates to the amount of its equity capital. The SBIC regulations currently limit the amount that our SBIC subsidiary may borrow to a maximum of $150 million. This means that our SBIC subsidiary may access the full $150 million maximum available if it has $75 million in regulatory capital. However, we are not required to capitalize this subsidiary with $75 million and may determine to capitalize it with a lesser amount. In addition, if we are able to obtain financing under the SBIC program, our SBIC subsidiary will be subject to regulation and oversight by the SBA, including requirements with respect to maintaining certain minimum financial ratios and other covenants.
In connection with the filing of our SBA license application, we will be applying for exemptive relief from the SEC to permit us to exclude the debt of our SBIC subsidiary guaranteed by the SBA from our consolidated asset coverage ratio, which will enable us to fund more investments with debt capital. There can be no assurance that we will be granted an SBIC license or that if granted it will be granted in a timely manner, that if we are granted an SBIC license we will be able to capitalize the subsidiary to $75 million to access the full $150 million maximum borrowing amount available, or that we will receive the exemptive relief from the SEC.
We cannot provide any assurance that these measures will provide sufficient sources of liquidity to support our operations and growth given the continued instability in the financial markets and the weak U.S. economy.
Contractual Obligations
There were no payment obligations for repayment of debt and other contractual obligations at November 30, 2011.
OFF-BALANCE SHEET ARRANGEMENTS
At November 30, 2011 and February 28, 2011, we did not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Our market risks have not changed materially from the risks reported in our Form 10-K for the year ended February 28, 2011.
Item 4. Controls and Procedures
(a) As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer and our chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934). Based on that evaluation, our chief executive officer and our chief financial officer have concluded that our current disclosure controls and procedures are effective in facilitating timely decisions regarding required disclosure of any material information relating to us that is required to be disclosed by us in the reports we file or submit under the Securities Exchange Act of 1934.
(b) There have been no changes in our internal control over financial reporting that occurred during the quarter ended November 30, 2011 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
Neither we nor our wholly-owned subsidiary, Saratoga Investment Funding LLC, are currently subject to any material legal proceedings.
Item 1A. Risk Factors
Other than as set forth below, there have been no material changes from the risk factors set forth in our annual report on Form 10-K for the year ended February 28, 2011.
Stockholders may incur dilution if we sell shares of our common stock in one or more offerings at prices below the then current net asset value per share of our common stock.
The 1940 Act prohibits us from selling shares of our common stock at a price below the current net asset value per share of such stock, with certain exceptions. One such exception is prior stockholder approval of issuances below net asset value provided that our board of directors makes certain determinations. At our 2011 annual meeting of stockholders, our stockholders approved a proposal that authorizes us to sell shares of our common stock below the then current net asset value per share of our common stock in one or more offerings for a period of one year ending on the earlier of September 27, 2012 or the date of our 2012 annual meeting of stockholders. Our board of directors adopted a policy that requires us to sell or issue shares of our common stock at an offering price per share that is not less than 85% of the then current net asset value per share pursuant to this proposal. No change can be made to this policy without unanimous approval of our independent directors. Continued access to this exception will require approval of similar proposals at future stockholder meetings.
If we were to sell shares of our common stock below net asset value per share, such sales would result in an immediate dilution to the net asset value per share. This dilution would occur as a result of the sale of shares at a price below the then current net asset value per share of our common stock and a proportionately greater decrease in a stockholder’s interest in our earnings and assets and voting interest in us than the increase in our assets resulting from such issuance.
Because the number of shares of common stock that could be so issued and the timing of any issuance is not currently known, the actual dilutive effect cannot be predicted.
The recent downgrade of the U.S. credit rating and the economic crisis in Europe could negatively impact our liquidity, financial condition and earnings.
Recent U.S. debt ceiling and budget deficit concerns, together with signs of deteriorating sovereign debt conditions in Europe, have increased the possibility of additional credit-rating downgrades and economic slowdowns. Although U.S. lawmakers passed legislation to raise the federal debt ceiling, Standard & Poor’s Ratings Services lowered its long-term sovereign credit rating on the United States from “AAA” to “AA+” in August 2011. The impact of this or any further downgrades to the U.S. government’s sovereign credit rating, or its perceived creditworthiness, and the impact of the current crisis in Europe with respect to the ability of certain European Union countries to continue to service their sovereign debt obligations is inherently unpredictable and could adversely effect the U.S. and global financial markets and economic conditions. There can be no assurance that governmental or other measures to aid economic recovery will be effective. These developments, and the government’s credit concerns in general, could cause interest rates and borrowing costs to rise, which may negatively impact our ability to access the debt markets on favorable terms. In addition, the decreased credit rating could create broader financial turmoil and uncertainty, which may weigh heavily on our stock price. Continued adverse economic conditions could have a material adverse effect on our business, financial condition and results of operations.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Not applicable.
Item 3. Defaults upon Senior Securities
Item 4. Removed and Reserved
Item 5. Other Information
Item 6. Exhibits
Listed below are the exhibits which are filed as part of this report (according to the number assigned to them in Item 601 of Regulation S-K):
Exhibit Number
Description of Document
31.1*
Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
31.2*
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
32.1*
Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)
32.2*
Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)
* Submitted herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: January 12, 2012
By
/s/ Christian L. Oberbeck
Christian L. Oberbeck
Chief Executive Officer and President
/s/ Richard A. Petrocelli
Richard A. Petrocelli
Chief Financial Officer, Chief Compliance Officer and Secretary